Identification	O
and	O
characterization	O
of	O
a	O
leukocyte-specific	O
component	O
of	O
the	O
nuclear	O
body	O
.	O

The	O
nuclear	O
body	O
(	O
NB	O
)	O
is	O
a	O
cellular	O
organelle	O
that	O
is	O
involved	O
in	O
the	O
pathogenesis	O
of	O
acute	O
promyelocytic	O
leukemia	O
and	O
viral	O
infection	O
.	O

The	O
NB	O
is	O
also	O
a	O
target	O
of	O
antibodies	B-protein
in	O
the	O
serum	O
of	O
patients	O
with	O
the	O
autoimmune	O
disease	O
primary	O
biliary	O
cirrhosis	O
.	O

In	O
this	O
study	O
,	O
serum	O
from	O
a	O
patient	O
with	O
primary	O
biliary	O
cirrhosis	O
was	O
used	O
to	O
identify	O
a	O
cDNA	O
encoding	O
a	O
novel	O
component	O
of	O
the	O
NB	O
,	O
a	O
140-kDa	B-protein
protein	I-protein
designated	O
Sp140	B-protein
.	O

The	O
predicted	O
amino	O
acid	O
sequence	O
of	O
the	O
amino-terminal	B-protein
portion	I-protein
of	O
Sp140	B-protein
was	O
similar	O
to	O
Sp100	B-protein
,	O
a	O
previously	O
identified	O
NB	B-protein
protein	I-protein
.	O

The	O
carboxyl	B-protein
portion	I-protein
of	O
Sp140	B-protein
contained	O
a	O
zinc-finger	B-protein
domain	I-protein
and	O
a	O
bromodomain	B-protein
,	O
motifs	O
that	O
are	O
present	O
in	O
proteins	O
regulating	O
gene	O
transcription	O
.	O

High	O
levels	O
of	O
Sp140	B-RNA
mRNA	I-RNA
were	O
detected	O
in	O
human	O
spleen	O
and	O
peripheral	B-cell_type
blood	I-cell_type
leukocytes	I-cell_type
,	O
but	O
not	O
other	O
human	O
tissues	O
.	O

The	O
level	O
of	O
SP140	B-RNA
mRNA	I-RNA
in	O
myeloid	B-cell_line
precursor	I-cell_line
cell	I-cell_line
lines	I-cell_line
HL60	B-cell_line
and	O
NB4	B-cell_line
markedly	O
increased	O
in	O
response	O
to	O
chemically	O
induced	O
cellular	O
differentiation	O
.	O

Immunohistochemical	O
techniques	O
were	O
used	O
to	O
demonstrate	O
that	O
SP140	B-protein
localized	O
to	O
the	O
NB	O
in	O
differentiated	O
HL60	B-cell_line
and	O
NB4	B-cell_line
cells	I-cell_line
.	O

The	O
location	O
of	O
Sp140	B-protein
in	O
the	O
NB	O
,	O
and	O
expression	O
of	O
this	O
gene	O
in	O
cells	O
involved	O
in	O
host	O
defense	O
,	O
suggest	O
that	O
Sp140	B-protein
may	O
be	O
involved	O
in	O
the	O
pathogenesis	O
of	O
acute	O
promyelocytic	O
leukemia	O
and	O
viral	O
infection	O
.	O

THE	NULL
JOURNAL	NULL
oF	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©	NULL
1996	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

271	NULL
,	NULL
No	NULL
.	NULL

46	NULL
,	NULL
Issue	NULL
of	NULL
November	NULL
15	NULL
,	NULL
pp	NULL
.	NULL

29198-29204	NULL
,	NULL
1996	NULL
Printed	NULL
in	NULL
U.S.A	NULL
.	NULL

Identification	NULL
and	NULL
Characterization	NULL
of	NULL
a	NULL
Leukocyte-specific	NULL
Component	NULL
of	NULL
the	NULL
Nuclear	NULL
Body*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
March	NULL
28	NULL
,	NULL
1996	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
July	NULL
30	NULL
,	NULL
1996	NULL
)	NULL
Donald	NULL
B.	NULL
Bloch	NULL
#	NULL
§	NULL
,	NULL
Suzanne	NULL
M.	NULL
de	NULL
la	NULL
Monte1	NULL
,	NULL
Pavel	NULL
Guigaourit	NULL
,	NULL
Andrew	NULL
Filippovti	NULL
,	NULL
and	NULL
Kenneth	NULL
D.	NULL
Bloch	NULL
From	NULL
the	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
and	NULL
the	NULL
$	NULL
Arthritis	NULL
Unit	NULL
,	NULL
Cardiovascular	NULL
Research	NULL
Center	NULL
,	NULL
and	NULL
the	NULL
Division	NULL
of	NULL
Neuropathology	NULL
,	NULL
Cancer	NULL
Center	NULL
,	NULL
of	NULL
the	NULL
General	NULL
Medical	NULL
Services	NULL
,	NULL
Massachusetts	NULL
General	NULL
Hospital	NULL
,	NULL
Boston	NULL
,	NULL
Massachusetts	NULL
02129	NULL
The	NULL
nuclear	NULL
body	NULL
(	NULL
NB	NULL
)	NULL
is	NULL
a	NULL
cellular	NULL
organelle	NULL
that	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
and	NULL
viral	NULL
infection	NULL
.	NULL

The	NULL
NB	NULL
is	NULL
also	NULL
a	NULL
target	NULL
of	NULL
antibodies	NULL
in	NULL
the	NULL
serum	NULL
of	NULL
patients	NULL
with	NULL
the	NULL
autoimmune	NULL
disease	NULL
primary	NULL
biliary	NULL
cirrhosis	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
serum	NULL
from	NULL
a	NULL
patient	NULL
with	NULL
primary	NULL
biliary	NULL
cirrhosis	NULL
was	NULL
used	NULL
to	NULL
identify	NULL
a	NULL
cDNA	NULL
encoding	NULL
a	NULL
novel	NULL
component	NULL
of	NULL
the	NULL
NB	NULL
,	NULL
a	NULL
140-kDa	NULL
protein	NULL
designated	NULL
Sp140	NULL
.	NULL

The	NULL
predicted	NULL
amino	NULL
acid	NULL
sequence	NULL
of	NULL
the	NULL
amino-terminal	NULL
portion	NULL
of	NULL
Sp140	NULL
was	NULL
similar	NULL
to	NULL
Sp100	NULL
,	NULL
a	NULL
previously	NULL
identified	NULL
NB	NULL
protein	NULL
.	NULL

The	NULL
carboxyl	NULL
portion	NULL
of	NULL
Sp1l40	NULL
contained	NULL
a	NULL
zinc-finger	NULL
domain	NULL
and	NULL
a	NULL
bromodomain	NULL
,	NULL
motifs	NULL
that	NULL
are	NULL
present	NULL
in	NULL
proteins	NULL
regulating	NULL
gene	NULL
transcription	NULL
.	NULL

High	NULL
levels	NULL
of	NULL
Sp140	NULL
mRNA	NULL
were	NULL
detected	NULL
in	NULL
human	NULL
spleen	NULL
and	NULL
peripheral	NULL
blood	NULL
leukocytes	NULL
,	NULL
but	NULL
not	NULL
other	NULL
human	NULL
tissues	NULL
.	NULL

The	NULL
level	NULL
of	NULL
SP140	NULL
mRNA	NULL
in	NULL
myeloid	NULL
precursor	NULL
cell	NULL
lines	NULL
HL60	NULL
and	NULL
NB4	NULL
markedly	NULL
increased	NULL
in	NULL
response	NULL
to	NULL
chemically	NULL
induced	NULL
cellular	NULL
differentiation	NULL
.	NULL

Immunohistochemical	NULL
techniques	NULL
were	NULL
used	NULL
to	NULL
demonstrate	NULL
that	NULL
SP140	NULL
localized	NULL
to	NULL
the	NULL
NB	NULL
in	NULL
differentiated	NULL
HL60	NULL
and	NULL
NB4	NULL
cells	NULL
.	NULL

The	NULL
location	NULL
of	NULL
Sp140	NULL
in	NULL
the	NULL
NB	NULL
,	NULL
and	NULL
expression	NULL
of	NULL
this	NULL
gene	NULL
in	NULL
cells	NULL
involved	NULL
in	NULL
host	NULL
defense	NULL
,	NULL
suggest	NULL
that	NULL
Sp140	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
and	NULL
viral	NULL
infection	NULL
.	NULL

The	NULL
nuclear	NULL
body	NULL
(	NULL
NB	NULL
!	NULL

;	NULL
also	NULL
known	NULL
as	NULL
nuclear	NULL
domain	NULL
10	NULL
,	NULL
PML	NULL
oncogenic	NULL
domain	NULL
,	NULL
and	NULL
Kr	NULL
body	NULL
)	NULL
is	NULL
a	NULL
nuclear	NULL
organelle	NULL
whose	NULL
function	NULL
is	NULL
unknown	NULL
(	NULL
1-3	NULL
)	NULL
.	NULL

Using	NULL
immunohistochemical	NULL
staining	NULL
,	NULL
NBs	NULL
appear	NULL
as	NULL
5-30	NULL
discrete	NULL
,	NULL
punctate	NULL
,	NULL
dotlike	NULL
regions	NULL
within	NULL
the	NULL
nucleus	NULL
.	NULL

The	NULL
NB	NULL
is	NULL
distinct	NULL
from	NULL
other	NULL
nuclear	NULL
domains	NULL
including	NULL
those	NULL
involved	NULL
in	NULL
DNA	NULL
replication	NULL
and	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
United	NULL
States	NULL
Public	NULL
Health	NULL
Service	NULL
Grants	NULL
ARO1866	NULL
and	NULL
DK51179	NULL
(	NULL
to	NULL
D.	NULL
B	NULL
.	NULL

B	NULL
.	NULL
)	NULL

,	NULL
HL45895	NULL
(	NULL
to	NULL
K.	NULL
D	NULL
.	NULL

B	NULL
.	NULL
)	NULL

,	NULL
and	NULL
NS29798	NULL
(	NULL
to	NULL
S.	NULL
M.	NULL
d.	NULL
1	NULL
.	NULL

M.	NULL
)	NULL
,	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
Sjdgren	NULL
's	NULL
Syndrome	NULL
Foundation	NULL
,	NULL
Inc.	NULL
,	NULL
and	NULL
Arthritis	NULL
Foundation	NULL
(	NULL
to	NULL
D.	NULL
B	NULL
.	NULL

B	NULL
.	NULL
)	NULL

,	NULL
and	NULL
by	NULL
a	NULL
grant	NULL
to	NULL
the	NULL
Cardiovascular	NULL
Research	NULL
Center	NULL
from	NULL
Bristol-Myers	NULL
Squibb	NULL
Pharmaceuticals	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
17834	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

The	NULL
nucleotide	NULL
sequence	NULL
(	NULL
s	NULL
)	NULL
reported	NULL
in	NULL
this	NULL
paper	NULL
has	NULL
been	NULL
submitted	NULL
to	NULL
the	NULL
GenBank	NULL
``	NULL
``	NULL
/EBI	NULL
Data	NULL
Bank	NULL
with	NULL
accession	NULL
number	NULL
(	NULL
s	NULL
)	NULL
U63420	NULL
§	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Massachusetts	NULL
General	NULL
Hospital-East	NULL
,	NULL
CNY-8	NULL
,	NULL
149	NULL
18th	NULL
St.	NULL
,	NULL
Charlestown	NULL
,	NULL
MA	NULL
02129	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
617-726-3780	NULL
;	NULL
Fax	NULL
:	NULL
617-726-5651	NULL
;	NULL
E-mail	NULL
:	NULL
bloch	NULL
@	NULL
helix.mgh	NULL
.	NULL

harvard.edu	NULL
.	NULL
'	NULL

The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
NB	NULL
,	NULL
nuclear	NULL
body	NULL
;	NULL
APL	NULL
,	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
;	NULL
5-RACE	NULL
,	NULL
rapid	NULL
amplification	NULL
of	NULL
cDNA	NULL
5	NULL
'	NULL
ends	NULL
;	NULL
GST	NULL
,	NULL
glutathione	NULL
S-transferase	NULL
;	NULL
HUVEC	NULL
,	NULL
human	NULL
umbilical	NULL
vein	NULL
endothelial	NULL
cells	NULL
;	NULL
IFN	NULL
,	NULL
interferon	NULL
;	NULL
ORF	NULL
,	NULL
open	NULL
reading	NULL
frame	NULL
;	NULL
PBC	NULL
,	NULL
primary	NULL
biliary	NULL
cirrhosis	NULL
;	NULL
RA	NULL
,	NULL
all-trans	NULL
retinoic	NULL
acid	NULL
;	NULL
RAR-a	NULL
,	NULL
retinoic	NULL
acid	NULL
receptor-a	NULL
;	NULL
ABC	NULL
,	NULL
avidin-biotin	NULL
complexes	NULL
;	NULL
PMA	NULL
,	NULL
phorbol	NULL
12-myristate	NULL
18-acetate	NULL
;	NULL
DAB	NULL
,	NULL
3,83'-diaminobenzimide	NULL
;	NULL
bp	NULL
,	NULL
base	NULL
pair	NULL
(	NULL
s	NULL
)	NULL
.	NULL

29198	NULL
mRNA	NULL
processing	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
components	NULL
of	NULL
the	NULL
NB	NULL
do	NULL
not	NULL
co-localize	NULL
with	NULL
kinetochores	NULL
or	NULL
centromeres	NULL
(	NULL
2	NULL
)	NULL
.	NULL

The	NULL
number	NULL
of	NULL
NBs	NULL
in	NULL
the	NULL
cell	NULL
and	NULL
the	NULL
intensity	NULL
of	NULL
antibody	NULL
staining	NULL
of	NULL
these	NULL
structures	NULL
increase	NULL
in	NULL
response	NULL
to	NULL
stimuli	NULL
including	NULL
interferons	NULL
(	NULL
IFNs	NULL
)	NULL
,	NULL
heat	NULL
shock	NULL
,	NULL
and	NULL
viral	NULL
infection	NULL
(	NULL
1	NULL
)	NULL
.	NULL

The	NULL
NB	NULL
is	NULL
a	NULL
target	NULL
of	NULL
autoantibodies	NULL
in	NULL
the	NULL
serum	NULL
of	NULL
patients	NULL
with	NULL
the	NULL
autoimmune	NULL
disease	NULL
primary	NULL
biliary	NULL
cirrhosis	NULL
(	NULL
PBC	NULL
)	NULL
.	NULL

Approximately	NULL
40	NULL
%	NULL
of	NULL
patients	NULL
with	NULL
PBC	NULL
have	NULL
antibodies	NULL
directed	NULL
against	NULL
this	NULL
structure	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

Serum	NULL
from	NULL
patients	NULL
with	NULL
PBC	NULL
was	NULL
used	NULL
to	NULL
identify	NULL
and	NULL
characterize	NULL
a	NULL
100-kDa	NULL
component	NULL
of	NULL
the	NULL
NB	NULL
which	NULL
was	NULL
designated	NULL
Sp100	NULL
(	NULL
Speckled	NULL
,	NULL
100-kDa	NULL
)	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Xie	NULL
et	NULL
al	NULL
.	NULL

(	NULL
7	NULL
)	NULL
demonstrated	NULL
that	NULL
fusion	NULL
of	NULL
Sp100	NULL
to	NULL
the	NULL
LexA	NULL
DNA	NULL
binding	NULL
domain	NULL
activated	NULL
gene	NULL
transcription	NULL
in	NULL
Saccharomyces	NULL
cerevisiae	NULL
.	NULL

The	NULL
authors	NULL
suggested	NULL
that	NULL
Sp100	NULL
may	NULL
participate	NULL
in	NULL
activation	NULL
of	NULL
transcription	NULL
of	NULL
specific	NULL
regions	NULL
in	NULL
the	NULL
genome	NULL
(	NULL
7	NULL
)	NULL
.	NULL

A	NULL
second	NULL
component	NULL
of	NULL
the	NULL
NB	NULL
,	NULL
designated	NULL
NDP52	NULL
,	NULL
was	NULL
characterized	NULL
using	NULL
a	NULL
murine	NULL
monoclonal	NULL
antibody	NULL
that	NULL
reacted	NULL
with	NULL
the	NULL
NB	NULL
(	NULL
1	NULL
,	NULL
8	NULL
)	NULL
.	NULL

A	NULL
cDNA	NULL
encoding	NULL
NDP52	NULL
was	NULL
identified	NULL
,	NULL
and	NULL
the	NULL
predicted	NULL
amino	NULL
acid	NULL
sequence	NULL
contained	NULL
coiled-coil	NULL
,	NULL
leucine	NULL
zipper	NULL
,	NULL
and	NULL
zinc-finger	NULL
motifs	NULL
.	NULL

One	NULL
or	NULL
more	NULL
of	NULL
these	NULL
domains	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
interactions	NULL
between	NULL
NDP52	NULL
and	NULL
other	NULL
components	NULL
of	NULL
the	NULL
NB	NULL
(	NULL
8	NULL
)	NULL
.	NULL

A	NULL
third	NULL
component	NULL
of	NULL
the	NULL
NB	NULL
,	NULL
designated	NULL
PML	NULL
,	NULL
was	NULL
identified	NULL
by	NULL
several	NULL
investigators	NULL
studying	NULL
the	NULL
t	NULL
(	NULL
15	NULL
;	NULL
17	NULL
)	NULL
translocation	NULL
associated	NULL
with	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
(	NULL
APL	NULL
)	NULL
(	NULL
9-12	NULL
)	NULL
.	NULL

In	NULL
this	NULL
translocation	NULL
,	NULL
the	NULL
amino-terminal	NULL
portion	NULL
of	NULL
PML	NULL
is	NULL
fused	NULL
to	NULL
the	NULL
retinoic	NULL
acid	NULL
receptor-	NULL
(	NULL
RAR-	NULL
@	NULL
)	NULL
.	NULL

PML	NULL
was	NULL
found	NULL
to	NULL
co-localize	NULL
with	NULL
Sp100	NULL
in	NULL
the	NULL
NB	NULL
(	NULL
13	NULL
,	NULL
14	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
PML-RAR-a	NULL
fusion	NULL
protein	NULL
in	NULL
APL	NULL
cells	NULL
appeared	NULL
to	NULL
disrupt	NULL
the	NULL
NB	NULL
;	NULL
in	NULL
these	NULL
cells	NULL
,	NULL
the	NULL
NB	NULL
antigens	NULL
were	NULL
detected	NULL
in	NULL
numerous	NULL
smaller	NULL
regions	NULL
in	NULL
the	NULL
nucleus	NULL
described	NULL
as	NULL
``	NULL
microspeckles	NULL
.	NULL
``	NULL

Treatment	NULL
of	NULL
APL	NULL
cells	NULL
with	NULL
retinoic	NULL
acid	NULL
(	NULL
RA	NULL
)	NULL
resulted	NULL
in	NULL
differentiation	NULL
of	NULL
myeloid	NULL
precursor	NULL
cells	NULL
and	NULL
reformation	NULL
of	NULL
NBs	NULL
(	NULL
3	NULL
,	NULL
13	NULL
,	NULL
14	NULL
)	NULL
.	NULL

In	NULL
patients	NULL
with	NULL
APL	NULL
,	NULL
treatment	NULL
with	NULL
RA	NULL
results	NULL
in	NULL
differentiation	NULL
of	NULL
leukemic	NULL
cells	NULL
and	NULL
temporary	NULL
disease	NULL
remission	NULL
(	NULL
15	NULL
)	NULL
.	NULL

PML	NULL
,	NULL
like	NULL
Sp100	NULL
and	NULL
NDP52	NULL
,	NULL
is	NULL
expressed	NULL
in	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
human	NULL
cell	NULL
lines	NULL
.	NULL

Immunoreactive	NULL
PML	NULL
was	NULL
detected	NULL
in	NULL
myeloid	NULL
precursor	NULL
cells	NULL
as	NULL
well	NULL
as	NULL
erythroblasts	NULL
and	NULL
megakaryocytes	NULL
in	NULL
the	NULL
bone	NULL
marrow	NULL
(	NULL
16	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
PML	NULL
was	NULL
detected	NULL
in	NULL
psoriatic	NULL
skin	NULL
lesions	NULL
,	NULL
hyperplastic	NULL
breast	NULL
and	NULL
colon	NULL
tissues	NULL
,	NULL
and	NULL
in	NULL
the	NULL
endometrial	NULL
mucosa	NULL
during	NULL
the	NULL
follicular	NULL
phase	NULL
of	NULL
the	NULL
menstrual	NULL
cycle	NULL
(	NULL
17	NULL
)	NULL
.	NULL

In	NULL
recent	NULL
studies	NULL
,	NULL
Sternsdorf	NULL
et	NULL
al	NULL
.	NULL

(	NULL
18	NULL
)	NULL
demonstrated	NULL
that	NULL
PML	NULL
,	NULL
like	NULL
Sp100	NULL
,	NULL
is	NULL
a	NULL
target	NULL
of	NULL
autoantibodies	NULL
in	NULL
patients	NULL
with	NULL
PBC	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
three	NULL
previously	NULL
identified	NULL
components	NULL
of	NULL
the	NULL
NB	NULL
is	NULL
enhanced	NULL
by	NULL
treatment	NULL
with	NULL
IFNs	NULL
(	NULL
8	NULL
,	NULL
19	NULL
,	NULL
20	NULL
)	NULL
.	NULL

Guldner	NULL
et	NULL
ol	NULL
.	NULL

(	NULL
19	NULL
)	NULL
suggested	NULL
that	NULL
enhanced	NULL
expression	NULL
of	NULL
Sp100	NULL
by	NULL
IFNs	NULL
reflects	NULL
a	NULL
role	NULL
for	NULL
Sp100	NULL
in	NULL
the	NULL
``	NULL
anti-viral	NULL
state	NULL
.	NULL
``	NULL

Doucas	NULL
et	NULL
al	NULL
.	NULL

(	NULL
20	NULL
)	NULL
demonstrated	NULL
that	NULL
IFN-induced	NULL
expression	NULL
of	NULL
PML	NULL
in	NULL
HEp2	NULL
cells	NULL
This	NULL
paper	NULL
is	NULL
available	NULL
on	NULL
line	NULL
at	NULL
http	NULL
:	NULL
//www-jbc.stanford.edu/jbe/	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Sp	NULL
140	NULL
Component	NULL
of	NULL
the	NULL
Nuclear	NULL
Body	NULL
was	NULL
associated	NULL
with	NULL
inhibition	NULL
of	NULL
adenovirus	NULL
replication	NULL
.	NULL

The	NULL
NB	NULL
is	NULL
a	NULL
site	NULL
of	NULL
interaction	NULL
between	NULL
viral	NULL
and	NULL
host	NULL
proteins	NULL
.	NULL

Maul	NULL
et	NULL
al	NULL
.	NULL

(	NULL
21	NULL
)	NULL
and	NULL
Maul	NULL
and	NULL
Everett	NULL
(	NULL
22	NULL
)	NULL
demonstrated	NULL
that	NULL
infection	NULL
of	NULL
cells	NULL
with	NULL
herpes	NULL
simplex	NULL
virus	NULL
type	NULL
I	NULL
resulted	NULL
in	NULL
disruption	NULL
of	NULL
the	NULL
NB	NULL
.	NULL

Using	NULL
herpes	NULL
simplex	NULL
virus	NULL
type	NULL
I	NULL
deletion	NULL
mutants	NULL
,	NULL
disruption	NULL
of	NULL
the	NULL
nuclear	NULL
body	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
a	NULL
result	NULL
of	NULL
the	NULL
action	NULL
of	NULL
the	NULL
viral	NULL
protein	NULL
ICPO	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
other	NULL
viral	NULL
proteins	NULL
,	NULL
including	NULL
the	NULL
adenovirus	NULL
E4-ORF3	NULL
protein	NULL
,	NULL
also	NULL
interact	NULL
with	NULL
this	NULL
nuclear	NULL
organelle	NULL
(	NULL
20	NULL
,	NULL
23	NULL
,	NULL
24	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
serum	NULL
from	NULL
a	NULL
patient	NULL
with	NULL
PBC	NULL
was	NULL
used	NULL
to	NULL
identify	NULL
a	NULL
cDNA	NULL
encoding	NULL
a	NULL
third	NULL
autoantigen	NULL
in	NULL
the	NULL
NB	NULL
.	NULL

In	NULL
keeping	NULL
with	NULL
the	NULL
nomenclature	NULL
introduced	NULL
for	NULL
Sp100	NULL
and	NULL
because	NULL
the	NULL
protein	NULL
has	NULL
an	NULL
apparent	NULL
molecular	NULL
weight	NULL
of	NULL
140	NULL
kDa	NULL
,	NULL
the	NULL
protein	NULL
was	NULL
designated	NULL
Sp140	NULL
.	NULL

High	NULL
levels	NULL
of	NULL
mRNA	NULL
encoding	NULL
Sp140	NULL
were	NULL
detected	NULL
in	NULL
human	NULL
spleen	NULL
and	NULL
peripheral	NULL
blood	NULL
leukocytes	NULL
.	NULL

As	NULL
with	NULL
the	NULL
other	NULL
components	NULL
of	NULL
the	NULL
NB	NULL
,	NULL
IFN	NULL
treatment	NULL
enhanced	NULL
expression	NULL
of	NULL
Sp140	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
high	NULL
levels	NULL
of	NULL
Sp140	NULL
mRNA	NULL
were	NULL
detected	NULL
in	NULL
myeloid	NULL
precursor	NULL
cell	NULL
lines	NULL
after	NULL
chemically	NULL
induced	NULL
cellular	NULL
differentiation	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Human	NULL
Serum-Serum	NULL
was	NULL
obtained	NULL
from	NULL
a	NULL
patient	NULL
with	NULL
PBC	NULL
.	NULL

The	NULL
diagnosis	NULL
was	NULL
based	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
elevated	NULL
liver	NULL
function	NULL
enzymes	NULL
and	NULL
high	NULL
titer	NULL
antibodies	NULL
directed	NULL
against	NULL
the	NULL
mitochondrial	NULL
antigen	NULL
E2-pyruvate	NULL
dehydrogenase	NULL
complex	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Cell	NULL
Culture	NULL
and	NULL
Induction	NULL
of	NULL
Differentiation-HLGO	NULL
cells	NULL
(	NULL
American	NULL
Type	NULL
Tissue	NULL
Collection	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
and	NULL
NBA4	NULL
cells	NULL
(	NULL
a	NULL
gift	NULL
of	NULL
M.	NULL
Lanotte	NULL
,	NULL
Institut	NULL
National	NULL
de	NULL
la	NULL
Sante	NULL
et	NULL
Recherche	NULL
Medicale	NULL
,	NULL
Paris	NULL
,	NULL
France	NULL
)	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
L-gluta-mine	NULL
(	NULL
2	NULL
mM	NULL
)	NULL
,	NULL
penicillin	NULL
(	NULL
200	NULL
units/ml	NULL
)	NULL
,	NULL
and	NULL
streptomycin	NULL
(	NULL
200	NULL
ug/ml	NULL
)	NULL
.	NULL

Differentiation	NULL
of	NULL
HL6O	NULL
cells	NULL
toward	NULL
monocytes	NULL
was	NULL
induced	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
phorbol	NULL
12-myristate	NULL
18-acetate	NULL
(	NULL
PMA	NULL
;	NULL
2	NULL
x	NULL
10~*	NULL
M	NULL
)	NULL
.	NULL

Differentiation	NULL
of	NULL
HL6O	NULL
cells	NULL
toward	NULL
polymorphonuclear	NULL
leukocytes	NULL
was	NULL
induced	NULL
by	NULL
incubation	NULL
with	NULL
dimethyl	NULL
sulfoxide	NULL
(	NULL
Me	NULL
,	NULL
S80O	NULL
;	NULL
1.2	NULL
%	NULL
)	NULL
(	NULL
26	NULL
,	NULL
27	NULL
)	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
IFN	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
Sp140	NULL
in	NULL
HL6O	NULL
cells	NULL
was	NULL
studied	NULL
by	NULL
incubating	NULL
these	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IFN-y	NULL
(	NULL
200	NULL
units/ml	NULL
)	NULL
.	NULL

Differentiation	NULL
of	NULL
NB4	NULL
cells	NULL
was	NULL
induced	NULL
by	NULL
treatment	NULL
for	NULL
5	NULL
days	NULL
with	NULL
all-trans	NULL
retinoic	NULL
acid	NULL
(	NULL
RA	NULL
;	NULL
1	NULL
uM	NULL
)	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Immunohistochemical	NULL
Staining-Adherent	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
tissue	NULL
culture	NULL
chambers	NULL
(	NULL
Nunc	NULL
,	NULL
Inc.	NULL
,	NULL
Naperville	NULL
,	NULL
IL	NULL
)	NULL
and	NULL
fixed	NULL
in	NULL
4	NULL
%	NULL
paraformaldehyde	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Cytospin	NULL
preparation	NULL
of	NULL
nonadherent	NULL
cells	NULL
was	NULL
performed	NULL
with	NULL
50,000	NULL
cells	NULL
at	NULL
500	NULL
rpm	NULL
for	NULL
5	NULL
min	NULL
followed	NULL
by	NULL
air	NULL
drying	NULL
and	NULL
fixation	NULL
in	NULL
paraformaldehyde	NULL
.	NULL

Prior	NULL
to	NULL
incubation	NULL
with	NULL
antibodies	NULL
,	NULL
cells	NULL
were	NULL
permeabilized	NULL
with	NULL
0.1	NULL
%	NULL
saponin	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
and	NULL
then	NULL
treated	NULL
with	NULL
0.6	NULL
%	NULL
hydrogen	NULL
peroxide	NULL
in	NULL
60	NULL
%	NULL
methanol	NULL
to	NULL
block	NULL
endogenous	NULL
peroxidase	NULL
activity	NULL
.	NULL

Cells	NULL
were	NULL
immunostained	NULL
with	NULL
mouse	NULL
monoclonal	NULL
antibody	NULL
directed	NULL
against	NULL
PML	NULL
(	NULL
a	NULL
gift	NULL
of	NULL
K.	NULL
van	NULL
Der	NULL
Kraan	NULL
,	NULL
E.	NULL
C.	NULL
Slater	NULL
Instituut	NULL
,	NULL
Amsterdam	NULL
)	NULL
(	NULL
29	NULL
)	NULL
or	NULL
rat	NULL
antiserum	NULL
directed	NULL
against	NULL
Sp140	NULL
using	NULL
horseradish	NULL
peroxidase-conjugated	NULL
avidin-biotin	NULL
complexes	NULL
(	NULL
ABC	NULL
)	NULL
(	NULL
Vector	NULL
ABC	NULL
Elite	NULL
Kit	NULL
;	NULL
Vector	NULL
Laboratories	NULL
)	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
,	NULL
cells	NULL
were	NULL
stained	NULL
with	NULL
rat	NULL
anti-Sp140	NULL
antibodies	NULL
that	NULL
were	NULL
affinity-purified	NULL
using	NULL
recombinant	NULL
protein	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

Cells	NULL
incubated	NULL
with	NULL
mouse	NULL
monoclonal	NULL
antibody	NULL
and	NULL
biotinylated	NULL
goat	NULL
anti-mouse	NULL
IgG	NULL
antiserum	NULL
were	NULL
subsequently	NULL
exposed	NULL
to	NULL
either	NULL
TruBlue	NULL
peroxidase	NULL
substrate	NULL
(	NULL
Kirkegaard-Perry	NULL
Laboratories	NULL
,	NULL
Inc.	NULL
,	NULL
Gaithers-burg	NULL
,	NULL
MD	NULL
)	NULL
,	NULL
which	NULL
resulted	NULL
in	NULL
blue	NULL
staining	NULL
or	NULL
3,3'-diaminobenzimide	NULL
(	NULL
DAB	NULL
)	NULL
which	NULL
produced	NULL
a	NULL
brown	NULL
precipitate	NULL
.	NULL

Similarly	NULL
,	NULL
cells	NULL
incubated	NULL
with	NULL
rat	NULL
anti-SP140	NULL
antiserum	NULL
and	NULL
biotinylated	NULL
goat	NULL
anti-rat	NULL
IgG	NULL
antiserum	NULL
were	NULL
treated	NULL
with	NULL
either	NULL
TruBlue	NULL
peroxidase	NULL
substrate	NULL
or	NULL
DAB	NULL
.	NULL

Control	NULL
studies	NULL
included	NULL
immunostaining	NULL
with	NULL
preimmune	NULL
rat	NULL
serum	NULL
and	NULL
anti-Sp140	NULL
antibodies	NULL
preasbsorbed	NULL
with	NULL
recombinant	NULL
protein	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

Double	NULL
immunostaining	NULL
reactions	NULL
were	NULL
used	NULL
to	NULL
determine	NULL
the	NULL
cellular	NULL
location	NULL
of	NULL
Sp140	NULL
relative	NULL
to	NULL
PML	NULL
.	NULL

Horseradish	NULL
peroxidase-conjugated	NULL
ABC	NULL
and	NULL
DAB	NULL
(	NULL
brown	NULL
chromagen	NULL
)	NULL
were	NULL
used	NULL
to	NULL
detect	NULL
PML	NULL
,	NULL
and	NULL
alkaline	NULL
phosphatase-conjugated	NULL
ABC	NULL
and	NULL
PhThalo	NULL
Blue	NULL
(	NULL
Kirkegaard-Perry	NULL
Laboratories	NULL
,	NULL
Inc.	NULL
)	NULL
were	NULL
used	NULL
to	NULL
detect	NULL
Sp140	NULL
.	NULL

Isolation	NULL
and	NULL
Preliminary	NULL
Analysis	NULL
of	NULL
cDNA	NULL
Clones-Patient	NULL
serum	NULL
diluted	NULL
1:200	NULL
in	NULL
blocking	NULL
solution	NULL
(	NULL
phosphate-buffered	NULL
saline	NULL
containing	NULL
5	NULL
%	NULL
nonfat	NULL
dry	NULL
milk	NULL
,	NULL
pH	NULL
7.4	NULL
)	NULL
was	NULL
used	NULL
to	NULL
screen	NULL
a	NULL
AGT11L	NULL
cDNA	NULL
expression	NULL
library	NULL
prepared	NULL
from	NULL
HepG2	NULL
(	NULL
human	NULL
hepatocellular	NULL
carcinoma	NULL
)	NULL
cells	NULL
(	NULL
Clontech	NULL
)	NULL
(	NULL
30	NULL
)	NULL
.	NULL

One	NULL
clone	NULL
expressing	NULL
immunoreactive	NULL
protein	NULL
was	NULL
isolated	NULL
from	NULL
approximately	NULL
one	NULL
million	NULL
bacteriophages	NULL
.	NULL

The	NULL
cDNA	NULL
29199	NULL
clone	NULL
(	NULL
Sp140.1	NULL
)	NULL
was	NULL
radiolabeled	NULL
and	NULL
used	NULL
to	NULL
screen	NULL
a	NULL
AGT1O	NULL
human	NULL
umbilical	NULL
vein	NULL
endothelial	NULL
cell	NULL
(	NULL
HUVEC	NULL
)	NULL
cDNA	NULL
library	NULL
(	NULL
81	NULL
)	NULL
.	NULL

One	NULL
positive	NULL
clone	NULL
(	NULL
8p140.2	NULL
)	NULL
was	NULL
identified	NULL
.	NULL

Amplification	NULL
of	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
cDNA	NULL
encoding	NULL
Sp140	NULL
was	NULL
performed	NULL
using	NULL
the	NULL
5'-RACE	NULL
system	NULL
(	NULL
Life	NULL
Technologies	NULL
Inc.	NULL
)	NULL
(	NULL
82	NULL
)	NULL
and	NULL
cDNA	NULL
prepared	NULL
from	NULL
human	NULL
placenta	NULL
(	NULL
Clon-tech	NULL
)	NULL
.	NULL

The	NULL
first	NULL
polymerase	NULL
chain	NULL
reaction	NULL
used	NULL
an	NULL
18-nucleotide	NULL
primer	NULL
(	NULL
GSP1	NULL
:	NULL
5'-CCTGAGGCACTGCTATAT-3	NULL
'	NULL
)	NULL
and	NULL
the	NULL
anchor	NULL
primer	NULL
supplied	NULL
by	NULL
the	NULL
manufacturer	NULL
.	NULL

A	NULL
second	NULL
,	NULL
``	NULL
nested	NULL
``	NULL
oligonucleotide	NULL
with	NULL
a	NULL
5	NULL
'	NULL
EcoRI	NULL
site	NULL
(	NULL
GSP2	NULL
:	NULL
5'-CGGAATTCGAAATGGCCTTGTTATTG-3	NULL
'	NULL
)	NULL
was	NULL
used	NULL
with	NULL
a	NULL
second	NULL
anchor	NULL
primer	NULL
(	NULL
modified	NULL
to	NULL
include	NULL
an	NULL
EcoRI	NULL
site	NULL
)	NULL
to	NULL
further	NULL
amplify	NULL
the	NULL
product	NULL
.	NULL

The	NULL
polymerase	NULL
chain	NULL
reaction	NULL
product	NULL
was	NULL
treated	NULL
with	NULL
EcoRI	NULL
and	NULL
ligated	NULL
into	NULL
pUC19	NULL
.	NULL

The	NULL
nucleotide	NULL
sequences	NULL
of	NULL
the	NULL
cDNAs	NULL
and	NULL
two	NULL
independent	NULL
5'-RACE	NULL
products	NULL
were	NULL
determined	NULL
by	NULL
the	NULL
dideoxy	NULL
chain	NULL
termination	NULL
method	NULL
(	NULL
83	NULL
)	NULL
.	NULL

In	NULL
Vitro	NULL
Transcription	NULL
and	NULL
Translation	NULL
of	NULL
Sp140-To	NULL
create	NULL
a	NULL
full-length	NULL
cDNA	NULL
encoding	NULL
Sp140	NULL
,	NULL
a	NULL
KprnUBstY¥I	NULL
fragment	NULL
of	NULL
the	NULL
5-RACE	NULL
product	NULL
and	NULL
a	NULL
BsfYU/EcoRI	NULL
fragment	NULL
of	NULL
cDNA	NULL
Sp140.2	NULL
were	NULL
ligated	NULL
into	NULL
the	NULL
KpnI	NULL
and	NULL
EcoRI	NULL
sites	NULL
in	NULL
eukaryotic	NULL
expression	NULL
vector	NULL
pCDNAS	NULL
(	NULL
Invitrogen	NULL
Corp.	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
to	NULL
create	NULL
plasmid	NULL
pCDNAS8-Sp140	NULL
.	NULL

The	NULL
plasmid	NULL
was	NULL
used	NULL
in	NULL
the	NULL
TnT	NULL
Reticulocyte	NULL
Lysate	NULL
System	NULL
(	NULL
Promega	NULL
Corp.	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
to	NULL
produce	NULL
in	NULL
vitro	NULL
translated	NULL
protein	NULL
.	NULL

Production	NULL
of	NULL
Rat	NULL
Antiserum-Male	NULL
Sprague-Dawley	NULL
rats	NULL
were	NULL
immunized	NULL
with	NULL
recombinant	NULL
protein	NULL
containing	NULL
Sp140	NULL
amino	NULL
acids	NULL
131-391	NULL
fused	NULL
to	NULL
glutathione	NULL
S-transferase	NULL
(	NULL
GST	NULL
)	NULL
.	NULL

The	NULL
plasmid	NULL
encoding	NULL
this	NULL
portion	NULL
of	NULL
Sp140	NULL
was	NULL
prepared	NULL
by	NULL
ligating	NULL
eDNA	NULL
Sp140.1	NULL
into	NULL
the	NULL
EcoRI	NULL
site	NULL
of	NULL
the	NULL
prokaryotic	NULL
expression	NULL
vector	NULL
pGEX	NULL
(	NULL
Pharmacia	NULL
Bio-tech	NULL
Inc.	NULL
)	NULL
.	NULL

The	NULL
plasmid	NULL
was	NULL
used	NULL
to	NULL
transform	NULL
Escherichia	NULL
coli	NULL
,	NULL
and	NULL
expression	NULL
of	NULL
the	NULL
fusion	NULL
protein	NULL
was	NULL
induced	NULL
by	NULL
treatment	NULL
with	NULL
isopro-pyl-1-thio-6-D-galactopyranoside	NULL
.	NULL

The	NULL
110-kDa	NULL
fusion	NULL
protein	NULL
was	NULL
purified	NULL
from	NULL
E.	NULL
coli	NULL
proteins	NULL
as	NULL
described	NULL
by	NULL
Smith	NULL
and	NULL
Johnson	NULL
(	NULL
84	NULL
)	NULL
.	NULL

Primary	NULL
immunization	NULL
of	NULL
three	NULL
rats	NULL
was	NULL
performed	NULL
using	NULL
50	NULL
ug	NULL
of	NULL
purified	NULL
protein	NULL
emulsified	NULL
in	NULL
complete	NULL
Freund	NULL
's	NULL
adjuvant	NULL
for	NULL
each	NULL
animal	NULL
.	NULL

Two	NULL
subsequent	NULL
booster	NULL
injections	NULL
consisting	NULL
of	NULL
50	NULL
ug	NULL
of	NULL
protein	NULL
were	NULL
given	NULL
at	NULL
2-week	NULL
intervals	NULL
.	NULL

Rat	NULL
antibodies	NULL
directed	NULL
against	NULL
Sp140	NULL
were	NULL
affinity-purified	NULL
using	NULL
nitrocellulose-bound	NULL
recombinant	NULL
protein	NULL
as	NULL
described	NULL
by	NULL
Olmsted	NULL
(	NULL
85	NULL
)	NULL
.	NULL

The	NULL
GST-Sp140-	NULL
(	NULL
181-391	NULL
)	NULL
fusion	NULL
protein	NULL
was	NULL
fractionated	NULL
by	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
and	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
as	NULL
described	NULL
below	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
incubated	NULL
in	NULL
blocking	NULL
solution	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
was	NULL
then	NULL
incubated	NULL
with	NULL
rat	NULL
antiserum	NULL
diluted	NULL
1:10	NULL
in	NULL
blocking	NULL
solution	NULL
.	NULL

Bound	NULL
antibodies	NULL
were	NULL
eluted	NULL
by	NULL
treatment	NULL
with	NULL
100	NULL
mM	NULL
glycine-HCl	NULL
(	NULL
pH	NULL
2.5	NULL
)	NULL
for	NULL
10	NULL
min	NULL
at	NULL
room	NULL
tem-perature	NULL
.	NULL

The	NULL
antibody	NULL
solution	NULL
was	NULL
neutralized	NULL
by	NULL
addition	NULL
of	NULL
1	NULL
M	NULL
Tris	NULL
buffer	NULL
(	NULL
pH	NULL
8.8	NULL
)	NULL
.	NULL

Affinity-purified	NULL
antibodies	NULL
were	NULL
concentrated	NULL
using	NULL
an	NULL
Amicon	NULL
concentrator	NULL
(	NULL
W.	NULL
R.	NULL
Grace	NULL
and	NULL
Co.	NULL
,	NULL
Beverly	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

To	NULL
confirm	NULL
the	NULL
specificity	NULL
of	NULL
anti-Sp140	NULL
antibodies	NULL
,	NULL
rat	NULL
antiserum	NULL
(	NULL
or	NULL
affinity-purified	NULL
anti-Sp140	NULL
antibodies	NULL
)	NULL
were	NULL
preincubated	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
purified	NULL
,	NULL
recombinant	NULL
protein	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
prior	NULL
to	NULL
use	NULL
in	NULL
immunoblot	NULL
or	NULL
immunohistochemistry	NULL
.	NULL

SDS-Polyacrylamide	NULL
Gel	NULL
Electrophoresis	NULL
and	NULL
Immunoblotting-Me	NULL
,	NULL
SO-treated	NULL
HL60	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
cold	NULL
phosphate-buffered	NULL
saline	NULL
containing	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
(	NULL
1	NULL
mM	NULL
)	NULL
,	NULL
leupeptin	NULL
(	NULL
2	NULL
uM	NULL
)	NULL
,	NULL
and	NULL
pepstatin	NULL
A	NULL
(	NULL
1	NULL
uM	NULL
)	NULL
.	NULL

Me	NULL
,	NULL
SO-treated	NULL
HL6O	NULL
cell	NULL
lysates	NULL
or	NULL
reticulocyte	NULL
lysates	NULL
containing	NULL
in	NULL
vitro	NULL
translated	NULL
protein	NULL
were	NULL
boiled	NULL
for	NULL
5	NULL
min	NULL
in	NULL
sample	NULL
buffer	NULL
(	NULL
0.125	NULL
m	NULL
Tris-HCl	NULL
,	NULL
4	NULL
%	NULL
SDS	NULL
,	NULL
20	NULL
%	NULL
glycerol	NULL
,	NULL
10	NULL
%	NULL
B-mercap-toethanol	NULL
)	NULL
.	NULL

Proteins	NULL
were	NULL
fractionated	NULL
in	NULL
8	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
according	NULL
to	NULL
the	NULL
method	NULL
of	NULL
Laemmli	NULL
(	NULL
86	NULL
)	NULL
and	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
membranes	NULL
(	NULL
87	NULL
)	NULL
.	NULL

Membranes	NULL
were	NULL
incubated	NULL
in	NULL
blocking	NULL
solution	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
1	NULL
h	NULL
and	NULL
were	NULL
then	NULL
incubated	NULL
in	NULL
human	NULL
serum	NULL
diluted	NULL
1:1000	NULL
in	NULL
blocking	NULL
solution	NULL
.	NULL

Bound	NULL
antibodies	NULL
were	NULL
visualized	NULL
by	NULL
incubation	NULL
with	NULL
horseradish	NULL
peroxidase-conjugated	NULL
protein	NULL
A	NULL
(	NULL
Amersham	NULL
)	NULL
and	NULL
enhanced	NULL
chemiluminescence	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

For	NULL
studies	NULL
using	NULL
rat	NULL
antiserum	NULL
,	NULL
membranes	NULL
were	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
antiserum	NULL
diluted	NULL
1:1000	NULL
in	NULL
blocking	NULL
solution	NULL
.	NULL

Bound	NULL
antibodies	NULL
were	NULL
detected	NULL
using	NULL
horseradish	NULL
peroxidase-conjugated	NULL
goat	NULL
anti-rat	NULL
antiserum	NULL
(	NULL
Amersham	NULL
)	NULL
and	NULL
chemiluminescence	NULL
.	NULL

RNA	NULL
Blot	NULL
Hybridization-The	NULL
level	NULL
of	NULL
mRNA	NULL
encoding	NULL
Sp140	NULL
in	NULL
human	NULL
tissues	NULL
was	NULL
determined	NULL
by	NULL
hybridizing	NULL
membranes	NULL
contained	NULL
2.5	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*-selected	NULL
RNA	NULL
from	NULL
human	NULL
tissues	NULL
(	NULL
multiple	NULL
tissue	NULL
Northern	NULL
blots	NULL
,	NULL
Clontech	NULL
Laboratories	NULL
)	NULL
with	NULL
a	NULL
``	NULL
P-radiolabeled	NULL
Sacl-EcoRI	NULL
fragment	NULL
of	NULL
Sp140	NULL
(	NULL
bp	NULL
2,089-2,905	NULL
)	NULL
.	NULL

Membranes	NULL
were	NULL
washed	NULL
under	NULL
stringent	NULL
conditions	NULL
and	NULL
were	NULL
exposed	NULL
to	NULL
autoradiography	NULL
for	NULL
9	NULL
h.	NULL
To	NULL
confirm	NULL
the	NULL
presence	NULL
of	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*-selected	NULL
RNA	NULL
in	NULL
each	NULL
lane	NULL
,	NULL
the	NULL
membranes	NULL
were	NULL
hybridized	NULL
with	NULL
a	NULL
*°P-radiolabeled	NULL
B-actin	NULL
cDNA	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
washed	NULL
under	NULL
stringent	NULL
conditions	NULL
and	NULL
exposed	NULL
to	NULL
autoradiography	NULL
for	NULL
30	NULL
min	NULL
.	NULL

RNA	NULL
was	NULL
extracted	NULL
from	NULL
human	NULL
cell	NULL
lines	NULL
using	NULL
the	NULL
guanidium	NULL
isothiocyanate/cesium	NULL
chloride	NULL
method	NULL
(	NULL
88	NULL
)	NULL
.	NULL

RNA	NULL
was	NULL
fractionated	NULL
in	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
29200	NULL
formaldehyde-agarose	NULL
gels	NULL
(	NULL
10	NULL
pg/lane	NULL
)	NULL
and	NULL
transferred	NULL
to	NULL
nylon	NULL
mem-branes	NULL
.	NULL

Membranes	NULL
were	NULL
hybridized	NULL
with	NULL
the	NULL
radiolabeled	NULL
Sacl/EcoRI	NULL
restriction	NULL
fragment	NULL
of	NULL
the	NULL
Sp140	NULL
cDNA	NULL
.	NULL

Membranes	NULL
were	NULL
washed	NULL
and	NULL
subjected	NULL
to	NULL
autoradiography	NULL
.	NULL

To	NULL
confirm	NULL
comparable	NULL
loading	NULL
of	NULL
RNA	NULL
in	NULL
each	NULL
lane	NULL
,	NULL
membranes	NULL
were	NULL
hybridized	NULL
with	NULL
a	NULL
10-fold	NULL
molar	NULL
excess	NULL
of	NULL
a	NULL
°°P-radiolabeled	NULL
oligonucleotide	NULL
complementary	NULL
to	NULL
rat	NULL
18	NULL
S	NULL
RNA	NULL
(	NULL
89	NULL
)	NULL
.	NULL

RESULTS	NULL
Isolation	NULL
of	NULL
a	NULL
cDNA	NULL
Encoding	NULL
Sp140-Patients	NULL
with	NULL
the	NULL
autoimmune	NULL
disease	NULL
PBC	NULL
produce	NULL
autoantibodies	NULL
directed	NULL
against	NULL
proteins	NULL
in	NULL
the	NULL
nuclear	NULL
body	NULL
.	NULL

To	NULL
identify	NULL
novel	NULL
components	NULL
of	NULL
this	NULL
structure	NULL
,	NULL
serum	NULL
from	NULL
a	NULL
patient	NULL
with	NULL
PBC	NULL
was	NULL
used	NULL
to	NULL
screen	NULL
a	NULL
AGT11	NULL
cDNA	NULL
expression	NULL
library	NULL
prepared	NULL
from	NULL
HEpG2	NULL
cells	NULL
.	NULL

Among	NULL
approximately	NULL
one	NULL
million	NULL
bacterio-phages	NULL
,	NULL
one	NULL
clone	NULL
(	NULL
§Sp140.1	NULL
)	NULL
producing	NULL
immunoreactive	NULL
recombinant	NULL
protein	NULL
was	NULL
identified	NULL
.	NULL

The	NULL
nucleotide	NULL
sequence	NULL
of	NULL
the	NULL
cDNA	NULL
was	NULL
found	NULL
to	NULL
contain	NULL
a	NULL
781-bp	NULL
open	NULL
reading	NULL
frame	NULL
(	NULL
ORF	NULL
)	NULL
that	NULL
extended	NULL
for	NULL
the	NULL
entire	NULL
length	NULL
of	NULL
the	NULL
fragment	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
cDNA	NULL
encoded	NULL
only	NULL
a	NULL
portion	NULL
of	NULL
a	NULL
protein	NULL
.	NULL

To	NULL
identify	NULL
a	NULL
full-length	NULL
cDNA	NULL
,	NULL
the	NULL
DNA	NULL
fragment	NULL
was	NULL
radiolabeled	NULL
and	NULL
used	NULL
to	NULL
rescreen	NULL
the	NULL
HEpG2	NULL
cDNA	NULL
library	NULL
;	NULL
no	NULL
additional	NULL
clones	NULL
were	NULL
identified	NULL
.	NULL

The	NULL
radiolabeled	NULL
fragment	NULL
was	NULL
then	NULL
used	NULL
to	NULL
screen	NULL
a	NULL
HUVEC	NULL
cDNA	NULL
library	NULL
,	NULL
and	NULL
a	NULL
single	NULL
hybridizing	NULL
cDNA	NULL
(	NULL
Sp140.2	NULL
)	NULL
was	NULL
identified	NULL
among	NULL
one	NULL
million	NULL
bacteriophages	NULL
.	NULL

The	NULL
clone	NULL
contained	NULL
a	NULL
2,732-bp	NULL
insert	NULL
that	NULL
included	NULL
the	NULL
entire	NULL
length	NULL
of	NULL
Sp140.1	NULL
.	NULL

A	NULL
2,193-nucleotide	NULL
ORF	NULL
extended	NULL
to	NULL
the	NULL
5	NULL
end	NULL
of	NULL
Sp140.2	NULL
,	NULL
suggesting	NULL
that	NULL
this	NULL
clone	NULL
also	NULL
encoded	NULL
only	NULL
part	NULL
of	NULL
the	NULL
full-length	NULL
protein	NULL
.	NULL

The	NULL
5'-RACE	NULL
technique	NULL
was	NULL
used	NULL
to	NULL
identify	NULL
the	NULL
5	NULL
end	NULL
of	NULL
the	NULL
mRNA	NULL
encoding	NULL
Sp140	NULL
.	NULL

The	NULL
RACE	NULL
product	NULL
contained	NULL
an	NULL
additional	NULL
173-bp	NULL
segment	NULL
.	NULL

The	NULL
polymerase	NULL
chain	NULL
reaction	NULL
product	NULL
and	NULL
the	NULL
5	NULL
end	NULL
of	NULL
Sp140.2	NULL
were	NULL
joined	NULL
at	NULL
a	NULL
BsfYI	NULL
!	NULL

site	NULL
,	NULL
and	NULL
the	NULL
full-length	NULL
cDNA	NULL
was	NULL
ligated	NULL
into	NULL
eukaryotic	NULL
expression	NULL
vector	NULL
pCDNA3	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
the	NULL
isolated	NULL
cDNA	NULL
encoded	NULL
a	NULL
protein	NULL
that	NULL
reacted	NULL
with	NULL
autoantibodies	NULL
in	NULL
the	NULL
patient	NULL
's	NULL
serum	NULL
,	NULL
the	NULL
plasmid	NULL
was	NULL
used	NULL
for	NULL
in	NULL
vitro	NULL
transcription	NULL
and	NULL
translation	NULL
of	NULL
Sp140	NULL
.	NULL

Autoantibodies	NULL
in	NULL
the	NULL
patient	NULL
's	NULL
serum	NULL
reacted	NULL
with	NULL
the	NULL
140-kDa	NULL
translation	NULL
product	NULL
by	NULL
immunoblot	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
panel	NULL
A	NULL
,	NULL
+	NULL
lane	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
this	NULL
band	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
a	NULL
lane	NULL
containing	NULL
reticulocyte	NULL
lysate	NULL
proteins	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
panel	NULL
A	NULL
,	NULL
-	NULL
lane	NULL
)	NULL
.	NULL

These	NULL
results	NULL
demonstrated	NULL
that	NULL
pCDNA3-Sp140	NULL
encoded	NULL
an	NULL
immunoreactive	NULL
protein	NULL
.	NULL

Sequence	NULL
Analysis	NULL
of	NULL
Sp140-The	NULL
cDNA	NULL
encoding	NULL
Sp140	NULL
was	NULL
2,905	NULL
bp	NULL
in	NULL
length	NULL
and	NULL
contained	NULL
an	NULL
ORF	NULL
from	NULL
107	NULL
to	NULL
2,365	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

The	NULL
start	NULL
codon	NULL
was	NULL
preceded	NULL
by	NULL
an	NULL
in-frame	NULL
stop	NULL
codon	NULL
.	NULL

Several	NULL
features	NULL
of	NULL
the	NULL
predicted	NULL
amino	NULL
acid	NULL
sequence	NULL
of	NULL
Sp140	NULL
were	NULL
of	NULL
interest	NULL
.	NULL

The	NULL
amino-terminal	NULL
portion	NULL
of	NULL
Sp140	NULL
,	NULL
between	NULL
amino	NULL
acids	NULL
29	NULL
and	NULL
157	NULL
,	NULL
was	NULL
49	NULL
%	NULL
identical	NULL
to	NULL
the	NULL
amino-terminal	NULL
region	NULL
of	NULL
Sp100	NULL
,	NULL
a	NULL
previously	NULL
identified	NULL
autoantigen	NULL
within	NULL
the	NULL
NB	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

The	NULL
region	NULL
in	NULL
Sp140	NULL
between	NULL
amino	NULL
acids	NULL
228-317	NULL
was	NULL
strongly	NULL
negatively	NULL
charged	NULL
.	NULL

Twenty-nine	NULL
of	NULL
the	NULL
92	NULL
amino	NULL
acids	NULL
in	NULL
this	NULL
region	NULL
were	NULL
either	NULL
glutamic	NULL
or	NULL
aspartic	NULL
acid	NULL
.	NULL

The	NULL
central	NULL
portion	NULL
of	NULL
Sp140	NULL
,	NULL
between	NULL
amino	NULL
acids	NULL
381-400	NULL
,	NULL
contained	NULL
a	NULL
potential	NULL
bipartite	NULL
nuclear	NULL
localization	NULL
sequence	NULL
(	NULL
40-42	NULL
)	NULL
.	NULL

The	NULL
carboxyl	NULL
portion	NULL
of	NULL
Sp140	NULL
contained	NULL
a	NULL
cysteine-rich	NULL
,	NULL
zinc-finger	NULL
motif	NULL
(	NULL
amino	NULL
acids	NULL
579-639	NULL
)	NULL
.	NULL

This	NULL
region	NULL
was	NULL
followed	NULL
by	NULL
a	NULL
segment	NULL
(	NULL
amino	NULL
acids	NULL
681-715	NULL
)	NULL
that	NULL
was	NULL
similar	NULL
to	NULL
the	NULL
bromodomain	NULL
in	NULL
S.	NULL
cerevisiae	NULL
protein	NULL
BDF1	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
(	NULL
48-45	NULL
)	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
a	NULL
strongly	NULL
negatively	NULL
charged	NULL
region	NULL
,	NULL
zinc-finger	NULL
motif	NULL
and	NULL
bromodomain	NULL
suggested	NULL
that	NULL
Sp140	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
gene	NULL
transcription	NULL
.	NULL

Expression	NULL
of	NULL
Sp140	NULL
in	NULL
Human	NULL
Tissues	NULL
and	NULL
Cell	NULL
Lines-The	NULL
expression	NULL
of	NULL
the	NULL
gene	NULL
encoding	NULL
Sp140	NULL
in	NULL
human	NULL
tissues	NULL
was	NULL
analyzed	NULL
by	NULL
RNA	NULL
blot	NULL
hybridization	NULL
.	NULL

High	NULL
levels	NULL
of	NULL
Sp1l40	NULL
mRNA	NULL
were	NULL
detected	NULL
in	NULL
human	NULL
spleen	NULL
and	NULL
peripheral	NULL
blood	NULL
leukocytes	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
much	NULL
lower	NULL
levels	NULL
of	NULL
Sp140	NULL
mRNA	NULL
were	NULL
observed	NULL
in	NULL
thymus	NULL
,	NULL
prostate	NULL
,	NULL
ovary	NULL
,	NULL
small	NULL
intes-tine	NULL
,	NULL
and	NULL
colon	NULL
.	NULL

Low	NULL
levels	NULL
of	NULL
a	NULL
slightly	NULL
smaller	NULL
transcript	NULL
,	NULL
Sp	NULL
140	NULL
Component	NULL
of	NULL
the	NULL
Nuclear	NULL
Body	NULL
200-	NULL
«	NULL
sme	NULL
»	NULL
mmm	NULL
<	NULL
bnoum-	NULL
-	NULL
<	NULL
-s	NULL
97-69-	NULL
t	NULL
comme	NULL
cmon	NULL
«	NULL
omume	NULL
«	NULL
ummm	NULL
46-	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Immunoblot	NULL
of	NULL
the	NULL
in	NULL
vitro	NULL
translation	NULL
product	NULL
of	NULL
the	NULL
Sp140	NULL
cDNA	NULL
.	NULL

Antibodies	NULL
in	NULL
human	NULL
serum	NULL
reacted	NULL
with	NULL
the	NULL
140-kDa	NULL
translation	NULL
product	NULL
,	NULL
as	NULL
well	NULL
as	NULL
other	NULL
reticulocyte	NULL
lysate	NULL
proteins	NULL
(	NULL
A	NULL
,	NULL
+	NULL
lane	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
140-kDa	NULL
band	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
a	NULL
lane	NULL
containing	NULL
only	NULL
reticulocyte	NULL
lysate	NULL
proteins	NULL
(	NULL
A	NULL
,	NULL
-	NULL
lane	NULL
)	NULL
.	NULL

Rat	NULL
antiserum	NULL
directed	NULL
against	NULL
Sp140	NULL
(	NULL
amino	NULL
acids	NULL
181-391	NULL
)	NULL
also	NULL
reacted	NULL
with	NULL
the	NULL
140-kDa	NULL
translation	NULL
product	NULL
(	NULL
B	NULL
.	NULL

+	NULL
lane	NULL
)	NULL
but	NULL
not	NULL
with	NULL
reticulocyte	NULL
lysate	NULL
proteins	NULL
(	NULL
B	NULL
,	NULL
-	NULL
lane	NULL
)	NULL
.	NULL

possibly	NULL
an	NULL
alternatively	NULL
spliced	NULL
form	NULL
of	NULL
Sp140	NULL
mRNA	NULL
,	NULL
were	NULL
detected	NULL
in	NULL
several	NULL
tissues	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
a	NULL
1,200-nucleotide	NULL
transcript	NULL
of	NULL
uncertain	NULL
significance	NULL
was	NULL
detected	NULL
in	NULL
human	NULL
testis	NULL
.	NULL

Very	NULL
low	NULL
levels	NULL
of	NULL
Sp140	NULL
mRNA	NULL
were	NULL
observed	NULL
in	NULL
human	NULL
heart	NULL
,	NULL
brain	NULL
,	NULL
placenta	NULL
,	NULL
lung	NULL
,	NULL
liver	NULL
,	NULL
skeletal	NULL
muscle	NULL
,	NULL
kidney	NULL
,	NULL
and	NULL
pancreas	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
expression	NULL
of	NULL
Sp140	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
monocyte/granulocyte	NULL
lineage	NULL
,	NULL
RNA	NULL
was	NULL
prepared	NULL
from	NULL
the	NULL
myeloid	NULL
precursor	NULL
cell	NULL
lines	NULL
HL60	NULL
and	NULL
NB4	NULL
before	NULL
and	NULL
after	NULL
induction	NULL
of	NULL
cellular	NULL
differentiation	NULL
.	NULL

Treatment	NULL
of	NULL
HL60	NULL
cells	NULL
with	NULL
Me,8O	NULL
induces	NULL
a	NULL
polymorphonuclear	NULL
leukocyte	NULL
morphology	NULL
;	NULL
treatment	NULL
with	NULL
PMA	NULL
induces	NULL
a	NULL
monocyte-like	NULL
morphology	NULL
(	NULL
26	NULL
,	NULL
27	NULL
)	NULL
.	NULL

Low	NULL
levels	NULL
of	NULL
Sp140	NULL
mRNA	NULL
were	NULL
detected	NULL
in	NULL
untreated	NULL
HL60	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
4	NULL
)	NULL
.	NULL

The	NULL
level	NULL
of	NULL
mRNA	NULL
was	NULL
increased	NULL
by	NULL
treatment	NULL
of	NULL
HL6O	NULL
cells	NULL
with	NULL
either	NULL
PMA	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
or	NULL
Me	NULL
,	NULL
SO	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
human	NULL
APL	NULL
cell	NULL
line	NULL
NB4	NULL
with	NULL
all-trans	NULL
retinoic	NULL
acid	NULL
(	NULL
RA	NULL
)	NULL
is	NULL
also	NULL
associated	NULL
with	NULL
cellular	NULL
differentiation	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Low	NULL
levels	NULL
of	NULL
Sp140	NULL
mRNA	NULL
were	NULL
detected	NULL
in	NULL
NB4	NULL
cells	NULL
prior	NULL
to	NULL
treatment	NULL
with	NULL
RA	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
5	NULL
days	NULL
after	NULL
addition	NULL
of	NULL
RA	NULL
(	NULL
1	NULL
pM	NULL
)	NULL
,	NULL
the	NULL
level	NULL
of	NULL
Sp1l40	NULL
mRNA	NULL
was	NULL
markedly	NULL
increased	NULL
(	NULL
Zane	NULL
8	NULL
)	NULL
.	NULL

These	NULL
results	NULL
demonstrated	NULL
that	NULL
differentiation	NULL
of	NULL
HL60	NULL
and	NULL
NB4	NULL
cells	NULL
was	NULL
associated	NULL
with	NULL
increased	NULL
expression	NULL
of	NULL
Sp140	NULL
.	NULL

IFN	NULL
Treatment	NULL
Induces	NULL
Expression	NULL
of	NULL
Sp140-The	NULL
expression	NULL
of	NULL
previously	NULL
characterized	NULL
components	NULL
of	NULL
the	NULL
NB	NULL
was	NULL
enhanced	NULL
by	NULL
treatment	NULL
of	NULL
cells	NULL
with	NULL
IFN	NULL
(	NULL
8	NULL
,	NULL
17	NULL
,	NULL
19	NULL
,	NULL
20	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
effect	NULL
of	NULL
IFN	NULL
on	NULL
the	NULL
level	NULL
of	NULL
Sp140	NULL
mRNA	NULL
,	NULL
HL6O	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
IFN-y	NULL
(	NULL
200	NULL
units/ml	NULL
)	NULL
.	NULL

Increased	NULL
Sp140	NULL
mRNA	NULL
levels	NULL
were	NULL
detected	NULL
24	NULL
h	NULL
after	NULL
treatment	NULL
and	NULL
persisted	NULL
for	NULL
at	NULL
least	NULL
4	NULL
days	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
treatment	NULL
with	NULL
IFN-y	NULL
further	NULL
increased	NULL
Sp140	NULL
mRNA	NULL
in	NULL
cells	NULL
treated	NULL
with	NULL
PMA	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
or	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

These	NULL
results	NULL
demonstrated	NULL
that	NULL
,	NULL
as	NULL
with	NULL
Sp100	NULL
,	NULL
NDP52	NULL
,	NULL
and	NULL
PML	NULL
,	NULL
expression	NULL
of	NULL
Sp140	NULL
was	NULL
enhanced	NULL
by	NULL
IFN-y	NULL
.	NULL

Cellular	NULL
Localization	NULL
of	NULL
Sp140-To	NULL
permit	NULL
cellular	NULL
localization	NULL
of	NULL
Sp140	NULL
by	NULL
immunohistochemical	NULL
techniques	NULL
,	NULL
antiserum	NULL
directed	NULL
against	NULL
a	NULL
recombinant	NULL
fragment	NULL
of	NULL
the	NULL
protein	NULL
was	NULL
prepared	NULL
.	NULL

Three	NULL
rats	NULL
were	NULL
immunized	NULL
with	NULL
Sp140	NULL
amino	NULL
acids	NULL
131-391	NULL
fused	NULL
to	NULL
GST	NULL
(	NULL
GST-Sp140-	NULL
(	NULL
131-391	NULL
)	NULL
)	NULL
.	NULL

The	NULL
resulting	NULL
antisera	NULL
reacted	NULL
with	NULL
the	NULL
in	NULL
vitro	NULL
translation	NULL
product	NULL
of	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Sp	NULL
140	NULL
Component	NULL
of	NULL
the	NULL
Nuclear	NULL
Body	NULL
29201	NULL
A	NULL
gtgctctt	NULL
Lgactgagcaccgaggyugcagt	NULL
tgucaget	NULL
tcace	NULL
Lcagage	NULL
cgaatcoggtectqgatcctaggecaagetc	NULL
atggcccagcagggccagcaggggcaaatggcaagtggagacagcaatctcaacttcaggatggtcgcagagatccagaacgtagagggtcaoaacctgcaggagcaggtttgccctgag	NULL
Mo	NULL
A	NULL
Q	NULL
Q	NULL
0	NULL
Q	NULL
Q	NULL
M	NULL
S	NULL
D	NULL
S	NULL
N	NULL
L	NULL
N	NULL
F	NULL
R	NULL
M	NULL
A	NULL
E	NULL
I	NULL
Q	NULL
N	NULL
V	NULL
E	NULL
@	NULL
Q	NULL
N	NULL
L	NULL
Q	NULL
E	NULL
Q	NULL
v	NULL
CP	NULL
40	NULL
cccattttcaggttcttcagagaaaacaaggtggagattgcaagtgcaataacaaggccatttoctttccortatgggectcogagacceqctocttcatctcogagcagatgtatgaacat	NULL
Po	NULL
I	NULL
F	NULL
ROF	NULL
F	NULL
R	NULL
E	NULL
N	NULL
K	NULL
V	NULL
E	NULL
I	NULL
A	NULL
S	NULL
A	NULL
I	NULL
T	NULL
ROB	NULL
F	NULL
P	NULL
F	NULL
L	NULL
M	NULL
G	NULL
L	NULL
R	NULL
D	NULL
RO	NULL
S	NULL
F	NULL
I	NULL
8	NULL
E	NULL
q	NULL
M	NULL
Y	NULL
E	NULL
H	NULL
80	NULL
tttcaagaagcttttagaaacctggtcccagtgacaagagtgatgtattgtgtactcagtgaactggagaagacatttggctggtcacatctggaagcattgttcagcaggattaacctg	NULL
Fo	NULL
Q	NULL
E0	NULL
A	NULL
F	NULL
R	NULL
N	NULL
L	NULL
Vv	NULL
Pov	NULL
T	NULL
R	NULL
Cov	NULL
L	NULL
$	NULL
E	NULL
L	NULL
K	NULL
F	NULL
G	NULL
W	NULL
S	NULL
H	NULL
L	NULL
E	NULL
A	NULL
L	NULL
F	NULL
S	NULL
R	NULL
NOL	NULL
120	NULL
atggcctatcctgatttaaacgagatttacagaagcttccagaatgtatgetatgaacactcacctctccasatgaataatgtaaacqgatttagaagatagacccagattactaccatat	NULL
Mo	NULL
A	NULL
¥	NULL
P	NULL
D	NULL
L	NULL
N	NULL
E	NULL
I	NULL
¥	NULL
ROS	NULL
F	NULL
Q	NULL
N	NULL
V	NULL
C	NULL
Y	NULL
E	NULL
H	NULL
§	NULL
P	NULL
L	NULL
Q	NULL
M	NULL
No	NULL
N	NULL
V	NULL
N	NULL
D	NULL
L	NULL
E	NULL
D	NULL
R	NULL
P	NULL
R	NULL
L	NULL
L	NULL
P	NULL
Y	NULL
160	NULL
ggtaaacaagagaacagcaatgcctgtcatgaaatggatgatatagcagtccctcaggaagccttgagctcctcggcaaggtgtgagccaggtttctcttcagagtcttgtgagcagtta	NULL
G	NULL
X	NULL
Q	NULL
E	NULL
NOS	NULL
N	NULL
A	NULL
C	NULL
H	NULL
E	NULL
M	NULL
D	NULL
D	NULL
I	NULL
A	NULL
V	NULL
P	NULL
Q	NULL
E	NULL
A	NULL
L	NULL
S	NULL
S	NULL
CoE	NULL
P	NULL
G	NULL
F	NULL
S	NULL
S	NULL
E	NULL
S	NULL
C	NULL
E	NULL
Q	NULL
L	NULL
200	NULL
gotctoccaaagqotggtogaggagatgetgaagatgcacccagectactaccagtgtectgtaaacttgctatacaaatagatgaaggagaatcagaagaaatgcccaagttactgcct	NULL
A	NULL
L	NULL
PK	NULL
A	NULL
G	NULL
G	NULL
G	NULL
D	NULL
A	NULL
E	NULL
D	NULL
A	NULL
B	NULL
S	NULL
L	NULL
L	NULL
BoV	NULL
S	NULL
C	NULL
K	NULL
L	NULL
A	NULL
I	NULL
Q	NULL
I	NULL
D	NULL
E	NULL
G	NULL
R	NULL
Ss	NULL
R	NULL
E	NULL
M	NULL
P	NULL
K	NULL
L	NULL
L	NULL
P	NULL
240	NULL
tatgatacagaagagacctttgntctaaaaactccccaagtcactaatgaaggagaaccagagaaggggctctgtctactaccaggtgaaggagaagagggcagtgatgactgttcggaa	NULL
¥	NULL
DoT	NULL
E	NULL
E	NULL
T	NULL
F	NULL
D	NULL
L	NULL
K	NULL
T	NULL
PB	NULL
Q	NULL
V	NULL
TP	NULL
N	NULL
E	NULL
G	NULL
E	NULL
PoE	NULL
C	NULL
C	NULL
L	NULL
L	NULL
RP	NULL
G	NULL
E	NULL
G	NULL
E	NULL
E	NULL
G	NULL
S	NULL
D	NULL
D	NULL
C	NULL
S	NULL
280	NULL
atgtgtgatggagaagagcgccaggaagcctctagctccctagcaagacgtgggtcagtgtcfagtgaactagaaaatcacccaatgaatgaagaaggagaatcagaagagcttgcttct	NULL
M	NULL
C	NULL
D	NULL
G	NULL
B	NULL
Q	NULL
B	NULL
A	NULL
S	NULL
S	NULL
§	NULL
L	NULL
A	NULL
R	NULL
G	NULL
S	NULL
s	NULL
s	NULL
E	NULL
L	NULL
E	NULL
N	NULL
H	NULL
P	NULL
M	NULL
N	NULL
E	NULL
E	NULL
G	NULL
E	NULL
S	NULL
E	NULL
E	NULL
L	NULL
A	NULL
S	NULL
320	NULL
agoctgctatatgataatgtaccaggagoggagcaatcagcatatgaaaatgagaagtgttcctgtgtcatgtgttt	NULL
ctcagaagaggtgccaggaagcccagaagcaaggacggaaagt	NULL
§	NULL
L	NULL
L	NULL
Y	NULL
D	NULL
N	NULL
V	NULL
P	NULL
G	NULL
A	NULL
E	NULL
Q	NULL
S	NULL
A	NULL
Y	NULL
E	NULL
N	NULL
E	NULL
K	NULL
C	NULL
S	NULL
C	NULL
v	NULL
M	NULL
C	NULL
F	NULL
S	NULL
E	NULL
E	NULL
v	NULL
P	NULL
G	NULL
S	NULL
P	NULL
R	NULL
S	NULL
360	NULL
aaaagagggcgcatgqctqgaqcaqaatgagaatgagaagg	NULL
gatcaagegtgtggcacaatggatactgtggatattgcaaacaactccact	NULL
ttgugaaaacccaagaqgaaaaga	NULL
a	NULL
K	NULL
_K	NULL
R	NULL
@	NULL
H	NULL
w	NULL
Ss	NULL
R	NULL
MR	NULL
M	NULL
R	NULL
R	NULL
]	NULL
400	NULL
aga	NULL
D	NULL
Q	NULL
A	NULL
C	NULL
G	NULL
T	NULL
M	NULL
D	NULL
T	NULL
V	NULL
D	NULL
I	NULL
A	NULL
N	NULL
N	NULL
S	NULL
T	NULL
L	NULL
G	NULL
K	NULL
[	NULL
BK	NULL
R	NULL
K	NULL
R	NULL
R	NULL
gataatagcaaagccgacggccaggtggtctccagtgaaaagaaggrgaacgrgaarrtgaaagacptttccaagaftagggggacaddgagaggcaaa	NULL
Q	NULL
K	NULL
NOS	NULL
Q	NULL
Q	NULL
N	NULL
D	NULL
N	NULL
Ss	NULL
K	NULL
A	NULL
D	NULL
G	NULL
g	NULL
v	NULL
v	NULL
Ss	NULL
§	NULL
B	NULL
K	NULL
K	NULL
A	NULL
N	NULL
NOL	NULL
K	NULL
D	NULL
L	NULL
S	NULL
K	NULL
I	NULL
R	NULL
G	NULL
R	NULL
X	NULL
R	NULL
G	NULL
K	NULL
440	NULL
cotggaaccogottcactcagagtgacagagotgcacagaaaagagtccgatcaagagcttcaagaaagcacaaagatgaaactgtggattttaaggetectttgcettocagigacctgt	NULL
PoG	NULL
T	NULL
R	NULL
F	NULL
T	NULL
Q	NULL
S	NULL
D	NULL
R	NULL
A	NULL
A	NULL
Q	NULL
K	NULL
R	NULL
V	NULL
R	NULL
S	NULL
R	NULL
A	NULL
S	NULL
R	NULL
K	NULL
H	NULL
K	NULL
DoE	NULL
T	NULL
VY	NULL
D	NULL
F	NULL
K	NULL
A	NULL
P	NULL
L	NULL
L	NULL
e	NULL
v	NULL
T	NULL
C	NULL
480	NULL
ggtggggtgaagggaattttacataagaagaaatfgcagcaaggaatc	NULL
tggtgaagtgtatacagactgaggatggasaatggttcaccoccacgqaatttgaaatcaaaggaggccat	NULL
I	NULL
L	NULL
H0	NULL
K	NULL
K	NULL
K	NULL
L	NULL
Q	NULL
Q	NULL
G	NULL
I	NULL
L	NULL
Y	NULL
K	NULL
C	NULL
I	NULL
Q	NULL
TP	NULL
E	NULL
D	NULL
G	NULL
K	NULL
W	NULL
F	NULL
T	NULL
BoT	NULL
E	NULL
F	NULL
ER	NULL
I	NULL
K	NULL
G	NULL
G	NULL
A	NULL
520	NULL
gcaagatcaaagaactggaggcotgagtgtgegctgtggegqqtqqccoctacgabggctgatggagaatggatttotgectgatcctccasgaatacgttacagqgaaaaaaaagagaata	NULL
Ro	NULL
S	NULL
K	NULL
N	NULL
W	NULL
R	NULL
L	NULL
S	NULL
V	NULL
R	NULL
C	NULL
G	NULL
G	NULL
w	NULL
P	NULL
L	NULL
R	NULL
W	NULL
L	NULL
M	NULL
E	NULL
N	NULL
G	NULL
>	NULL
H	NULL
L	NULL
B	NULL
D	NULL
B	NULL
P	NULL
R	NULL
I	NULL
R	NULL
Y	NULL
R	NULL
K	NULL
K	NULL
K	NULL
R	NULL
I	NULL
560	NULL
ctgaagfctcaaaacaatagctcagttgacccttqtatgagaaacctqqatqaqtqtqaqgtgtgccgggacggaggggagctgttctgttgcgacacttgttcaagagtcPtccatgag	NULL
Lok	NULL
s	NULL
Q	NULL
N	NULL
N	NULL
s	NULL
s	NULL
v	NULL
D	NULL
P	NULL
C	NULL
M	NULL
R	NULL
N	NULL
L	NULL
D	NULL
E	NULL
€	NULL
)	NULL
rR	NULL
v	NULL
€	NULL
)	NULL
R	NULL
a	NULL
r	NULL
c	NULL
©	NULL
bo	NULL
t	NULL
€	NULL
)	NULL
s	NULL
r	NULL
v	NULL
r	NULL
®	NULL
)	NULL
®	NULL
600	NULL
gactgtcacatcccgcctctggaagctgagagcaccccgtggaattgcatcttctgcaggatgaaggngtctccgggaagccaacagtgttgLcaggaatctcaqgtcctqqaqaggcag	NULL
p	NULL
©	NULL
)	NULL
k	NULL
f	NULL
r	NULL
r	NULL
v	NULL
R	NULL
A	NULL
E	NULL
R	NULL
T	NULL
P	NULL
W	NULL
©IF©R	NULL
Po	NULL
G	NULL
s	NULL
Q	NULL
Q	NULL
C	NULL
C	NULL
Q	NULL
B	NULL
S	NULL
E	NULL
V	NULL
L	NULL
%	NULL
R	NULL
0	NULL
640	NULL
atgtgtcctgaggaacagttgaaatgtgagttcctcctcttgaaagtctattgctgttctgagagctccttttttgccaagattccatactattattatart	NULL
?	NULL

gagaggcg	NULL
gtcaaggc	NULL
Mo	NULL
C	NULL
>	NULL
Q	NULL
CoE	NULL
F	NULL
L	NULL
LoL	NULL
K	NULL
v	NULL
vy	NULL
C	NULL
C	NULL
Ss	NULL
§§	NULL
F	NULL
F	NULL
A	NULL
K	NULL
I	NULL
B	NULL
Y	NULL
¥	NULL
¥	NULL
¥	NULL
I	NULL
R	NULL
E	NULL
A	NULL
C	NULL
Q	NULL
680	NULL
ctgaaggagcccatgtggttggataaaatcaagaaaaggctgaatgagcacggttacccccaagtggaggggtttgtacaadacatgcgcctcatcttccagaaccacaaggcctcttac	NULL
L	NULL
K	NULL
B	NULL
P	NULL
M	NULL
W	NULL
L	NULL
D	NULL
K	NULL
I	NULL
K	NULL
K	NULL
g	NULL
y	NULL
Pr	NULL
Q	NULL
v	NULL
@	NULL
FLV	NULL
Q	NULL
D	NULL
MOR	NULL
L	NULL
I	NULL
F	NULL
Q	NULL
N	NULL
HR	NULL
A	NULL
S	NULL
Y	NULL
720	NULL
aagtacaagqattttggccaaatgggatttagactggagectgagtttgagaagaatttcaaggaagtgtttgctattcaggaaacaaatgugaacaattgactggattagtggatgctq	NULL
Ko	NULL
Y	NULL
K	NULL
DoF	NULL
G	NULL
Q	NULL
M	NULL
G	NULL
F	NULL
R	NULL
L	NULL
E	NULL
A	NULL
ROF	NULL
E	NULL
K	NULL
NOF	NULL
K	NULL
E	NULL
V	NULL
F	NULL
A	NULL
I	NULL
Q	NULL
E	NULL
T	NULL
N	NULL
G	NULL
N	NULL
N	NULL
753	NULL
aaagcattcagcaaatggcacectasaatatgcogotggtttgecactgacttcaaaatgaggtcact	NULL
tqggcacageacatgcagggaggggcetttEetctgagectacttcatctgec	NULL
caaagacaaatoctcaaaaggaaattcaatcatcatgaatcacaacoccaagtatotcatcagccaggqgaagagtaagtqgggatcacagggaaggatgttqgcagegacaccatcccata	NULL
toogtggccacctcoatgcagaagocctaageccacattctttcaatagctcaoggtggtgcatgagtgtccatcatctgactcttctoggagtctcatattttgtgggactccotgtgca	NULL
aacatatgttattaaaatttttttoctcctgtaaaggaa	NULL
B	NULL
Sp140	NULL
29	NULL
EGQNLQEQVCPEPIFRFFRENKVEIASAITRPFPFLMGLRDRSFISEQMYEHFQEAFRNL	NULL
88	NULL
E	NULL
Q	NULL
+	NULL
+++	NULL
+	NULL
+F+	NULL
F+	NULL
NKVEI++AL	NULL
+	NULL
FPFL	NULL
GLRDR	NULL
I+	NULL
+M+E	NULL
Q++	NULL
RNL	NULL
sp100	NULL
40	NULL
EDQGVDDRLLYDIVFKHFKRNKVEISNAIKKTFPFLEGLRDRDLITNKMFEDSQDSCRNL	NULL
99	NULL
Sp140	NULL
89	NULL
VPVTRVMYCVLSELEKTFGWSHLEALFSRINLMAYPDLNEIYRSFQNVCYEHSPLQMNNV	NULL
148	NULL
VPV	NULL
RV+Y	NULL
VLSELEKTF	NULL
LEALFS	NULL
+N+	NULL
YPDL	NULL
IY+	NULL
F+NV	NULL
++	NULL
PLQ	NULL
+	NULL
sp100	NULL
100	NULL
VPVORVVYNVLSELEKTFNLPVLEALFSDVNMQEYPDLIHIYKGFENVIHDKLPLORSEE	NULL
159	NULL
Sp140	NULL
149	NULL
NDLEDRPRL	NULL
157	NULL
+	NULL
E+R	NULL
L	NULL
Sp100	NULL
160	NULL
EEREERSGL	NULL
168	NULL
C	NULL
Sp1l40	NULL
684	NULL
LKEPMWLDKIKKRLNEHGYPQVEGFVQDMRLIFQN	NULL
718	NULL
+KEPM	NULL
L	NULL
-	NULL
I	NULL
K+LN+	NULL
¥	NULL
+E	NULL
F	NULL
+D+RL+F+N	NULL
BDF1	NULL
357	NULL
VKEPMDLGTIAKKLNDWOYOTMEDFERDVRLVFKN	NULL
391	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Panel	NULL
A	NULL
,	NULL
the	NULL
nucleotide	NULL
and	NULL
predicted	NULL
amino	NULL
acid	NULL
sequences	NULL
of	NULL
Sp140	NULL
.	NULL

The	NULL
region	NULL
of	NULL
similarity	NULL
between	NULL
the	NULL
amino-terminal	NULL
portions	NULL
of	NULL
Sp140	NULL
and	NULL
Sp100	NULL
is	NULL
indicated	NULL
in	NULL
italics	NULL
.	NULL

A	NULL
presumed	NULL
nuclear	NULL
localization	NULL
sequence	NULL
is	NULL
present	NULL
between	NULL
amino	NULL
acids	NULL
381-400	NULL
(	NULL
indicated	NULL
by	NULL
a	NULL
box	NULL
)	NULL
.	NULL

Conserved	NULL
cysteine/histidine	NULL
residues	NULL
in	NULL
the	NULL
zinc-finger	NULL
motif	NULL
are	NULL
circled	NULL
.	NULL

The	NULL
bromodomain	NULL
between	NULL
amino	NULL
acids	NULL
681	NULL
and	NULL
715	NULL
is	NULL
underlined	NULL
.	NULL

These	NULL
sequence	NULL
data	NULL
are	NULL
available	NULL
from	NULL
GenBank	NULL
``	NULL
/EMBL/DDBJ	NULL
under	NULL
accession	NULL
no	NULL
.	NULL

U63420	NULL
.	NULL

Panel	NULL
B	NULL
,	NULL
comparison	NULL
between	NULL
the	NULL
amino-terminal	NULL
regions	NULL
of	NULL
Sp140	NULL
and	NULL
Sp100	NULL
.	NULL

Forty-nine	NULL
percent	NULL
of	NULL
the	NULL
amino	NULL
acids	NULL
in	NULL
this	NULL
region	NULL
are	NULL
identical	NULL
.	NULL

Pane	NULL
!	NULL

C	NULL
,	NULL
comparison	NULL
between	NULL
Sp140	NULL
amino	NULL
acids	NULL
681	NULL
and	NULL
715	NULL
and	NULL
a	NULL
bromodomain	NULL
in	NULL
S.	NULL
cerevisiae	NULL
protein	NULL
BDF1	NULL
.	NULL

Seventeen	NULL
of	NULL
85	NULL
amino	NULL
acids	NULL
in	NULL
this	NULL
region	NULL
are	NULL
identical	NULL
.	NULL

610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
29202	NULL
©	NULL
5	NULL
I7	NULL
a	NULL
©	NULL
©	NULL
o	NULL
®	NULL
s	NULL
$	NULL
®	NULL
E	NULL
_	NULL
g	NULL
$	NULL
E	NULL
u	NULL
2	NULL
a	NULL
m	NULL
5	NULL
$	NULL
8	NULL
a	NULL
P	NULL
f	NULL
$	NULL
§	NULL
5	NULL
G	NULL
f	NULL
a	NULL
<	NULL
a	NULL
82	NULL
3	NULL
a	NULL
o	NULL
®	NULL
9.5-7.5-	NULL
6	NULL
actin-	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Identification	NULL
of	NULL
Sp140	NULL
mRNA	NULL
in	NULL
human	NULL
tissues	NULL
by	NULL
RNA	NULL
blot	NULL
hybridization	NULL
.	NULL

A	NULL
membrane	NULL
containing	NULL
2.5	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
®	NULL
RNA	NULL
per	NULL
lane	NULL
of	NULL
human	NULL
spleen	NULL
,	NULL
thymus	NULL
,	NULL
prostate	NULL
,	NULL
testis	NULL
,	NULL
ovary	NULL
,	NULL
small	NULL
intes-tine	NULL
,	NULL
colon	NULL
,	NULL
and	NULL
peripheral	NULL
blood	NULL
leukocytes	NULL
was	NULL
hybridized	NULL
with	NULL
a	NULL
*°P-radiolabeled	NULL
Sacl/EcoRI	NULL
fragment	NULL
of	NULL
the	NULL
Sp140	NULL
cDNA	NULL
.	NULL

After	NULL
washing	NULL
under	NULL
stringent	NULL
conditions	NULL
,	NULL
the	NULL
membrane	NULL
was	NULL
exposed	NULL
to	NULL
autoradiography	NULL
.	NULL

High	NULL
levels	NULL
of	NULL
mRNA	NULL
encoding	NULL
Sp140	NULL
were	NULL
detected	NULL
in	NULL
human	NULL
spleen	NULL
and	NULL
peripheral	NULL
blood	NULL
leukocytes	NULL
.	NULL

To	NULL
confirm	NULL
the	NULL
presence	NULL
of	NULL
RNA	NULL
in	NULL
each	NULL
lane	NULL
,	NULL
the	NULL
membrane	NULL
was	NULL
subsequently	NULL
hybridized	NULL
with	NULL
a	NULL
human	NULL
B-actin	NULL
cDNA	NULL
probe	NULL
.	NULL

1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
T	NULL
8	NULL
Sp140-	NULL
r	NULL
``	NULL
1	NULL
woe	NULL
wane	NULL
_	NULL
a	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Expression	NULL
of	NULL
Sp140	NULL
mRNA	NULL
in	NULL
myeloid	NULL
precursor	NULL
cell	NULL
lines	NULL
.	NULL

Low	NULL
levels	NULL
of	NULL
Sp140	NULL
mRNA	NULL
were	NULL
detected	NULL
in	NULL
HL6O	NULL
cells	NULL
(	NULL
Zanes	NULL
I	NULL
and	NULL
4	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
HL6O0	NULL
cells	NULL
with	NULL
PMA	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
or	NULL
Me,580	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
markedly	NULL
increased	NULL
Sp140	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
level	NULL
of	NULL
Sp140	NULL
mRNA	NULL
was	NULL
further	NULL
increased	NULL
by	NULL
combinations	NULL
of	NULL
PMA	NULL
and	NULL
IFN-y	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
or	NULL
Me	NULL
,	NULL
S50	NULL
and	NULL
IFN-y	NULL
(	NULL
Zane	NULL
6	NULL
)	NULL
.	NULL

Low	NULL
levels	NULL
of	NULL
Sp140	NULL
mRNA	NULL
were	NULL
detected	NULL
in	NULL
NB4	NULL
cells	NULL
(	NULL
Zane	NULL
7	NULL
)	NULL
.	NULL

After	NULL
5	NULL
days	NULL
of	NULL
incubation	NULL
with	NULL
RA	NULL
,	NULL
the	NULL
level	NULL
of	NULL
Sp140	NULL
mRNA	NULL
was	NULL
markedly	NULL
increased	NULL
(	NULL
Zane	NULL
8	NULL
)	NULL
.	NULL

To	NULL
confirm	NULL
comparable	NULL
loading	NULL
of	NULL
RNA	NULL
in	NULL
each	NULL
lane	NULL
,	NULL
membranes	NULL
were	NULL
hybridized	NULL
with	NULL
a	NULL
10-fold	NULL
molar	NULL
excess	NULL
of	NULL
*°P-radiolabeled	NULL
oligonucleotide	NULL
complimentary	NULL
to	NULL
18	NULL
S	NULL
RNA	NULL
.	NULL

pCDNA3-Sp140	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
+	NULL
lane	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
antisera	NULL
reacted	NULL
with	NULL
a	NULL
140-kDa	NULL
band	NULL
in	NULL
an	NULL
immunoblot	NULL
prepared	NULL
from	NULL
Me	NULL
,	NULL
SO-treated	NULL
HL6O0	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

Pretreatment	NULL
of	NULL
rat	NULL
antiserum	NULL
with	NULL
recombinant	NULL
GST-Sp140-	NULL
(	NULL
131-391	NULL
)	NULL
blocked	NULL
re-activity	NULL
with	NULL
the	NULL
140-kDa	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

These	NULL
results	NULL
demonstrated	NULL
that	NULL
rat	NULL
antiserum	NULL
reacted	NULL
with	NULL
Sp140	NULL
.	NULL

Although	NULL
the	NULL
region	NULL
of	NULL
Sp140	NULL
used	NULL
to	NULL
immunize	NULL
rats	NULL
contained	NULL
a	NULL
short	NULL
segment	NULL
that	NULL
was	NULL
similar	NULL
to	NULL
Sp100	NULL
(	NULL
9	NULL
of	NULL
27	NULL
amino	NULL
acids	NULL
identical	NULL
)	NULL
,	NULL
the	NULL
rat	NULL
antiserum	NULL
did	NULL
not	NULL
react	NULL
with	NULL
Sp100	NULL
by	NULL
im-munoblot	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
rat	NULL
antiserum	NULL
did	NULL
not	NULL
stain	NULL
NBs	NULL
in	NULL
HEp2	NULL
cells	NULL
,	NULL
a	NULL
cell	NULL
line	NULL
that	NULL
contains	NULL
high	NULL
levels	NULL
of	NULL
Sp100	NULL
,	NULL
but	NULL
only	NULL
very	NULL
low	NULL
levels	NULL
of	NULL
Sp140	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
cellular	NULL
location	NULL
of	NULL
Sp140	NULL
,	NULL
affinity-purified	NULL
rat	NULL
anti-Sp1l40	NULL
antibodies	NULL
were	NULL
prepared	NULL
and	NULL
used	NULL
to	NULL
stain	NULL
Me	NULL
,	NULL
SO-treated	NULL
HL6O	NULL
cells	NULL
.	NULL

Antibodies	NULL
reacted	NULL
with	NULL
5-20	NULL
punce-tate	NULL
structures	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
these	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
panel	NULL
A	NULL
)	NULL
.	NULL

Sp	NULL
140	NULL
Component	NULL
of	NULL
the	NULL
Nuclear	NULL
Body	NULL
18S-	NULL
1	NULL
2	NULL
3	NULL
4	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Effect	NULL
of	NULL
IFN-y	NULL
treatment	NULL
on	NULL
the	NULL
level	NULL
of	NULL
Sp140	NULL
mRNA	NULL
in	NULL
HLG6O	NULL
cells	NULL
.	NULL

Low	NULL
levels	NULL
of	NULL
Sp140	NULL
mRNA	NULL
were	NULL
detected	NULL
in	NULL
untreated	NULL
HL6O	NULL
cells	NULL
(	NULL
Zane	NULL
1	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
Sp140	NULL
mRNA	NULL
was	NULL
enhanced	NULL
1	NULL
,	NULL
2	NULL
,	NULL
and	NULL
4	NULL
days	NULL
after	NULL
addition	NULL
of	NULL
IFN-y	NULL
(	NULL
Zanes	NULL
2	NULL
,	NULL
3	NULL
,	NULL
and	NULL
4	NULL
)	NULL
.	NULL

To	NULL
confirm	NULL
comparable	NULL
loading	NULL
of	NULL
RNA	NULL
in	NULL
each	NULL
lane	NULL
,	NULL
membranes	NULL
were	NULL
hybridized	NULL
with	NULL
a	NULL
10-fold	NULL
molar	NULL
excess	NULL
of	NULL
°°P-radiolabeled	NULL
oligonucleotide	NULL
complimentary	NULL
to	NULL
18	NULL
S	NULL
RNA	NULL
.	NULL

1	NULL
2	NULL
200-	NULL
*	NULL
«	NULL
us	NULL
97-69-	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

Immunoblot	NULL
of	NULL
Me	NULL
,	NULL
SO-treated	NULL
HL6O	NULL
cell	NULL
proteins	NULL
.	NULL

Serum	NULL
from	NULL
a	NULL
rat	NULL
immunized	NULL
with	NULL
a	NULL
fusion	NULL
protein	NULL
containing	NULL
GST-Sp140-	NULL
(	NULL
131-391	NULL
)	NULL
reacted	NULL
with	NULL
a	NULL
140-kDa	NULL
protein	NULL
in	NULL
Me,50-treated	NULL
HL6O	NULL
cells	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
normal	NULL
rat	NULL
serum	NULL
did	NULL
not	NULL
react	NULL
with	NULL
this	NULL
protein	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Rat	NULL
antiserum	NULL
preincubated	NULL
with	NULL
recombinant	NULL
protein	NULL
did	NULL
not	NULL
react	NULL
with	NULL
Sp140	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

This	NULL
is	NULL
the	NULL
same	NULL
pattern	NULL
as	NULL
that	NULL
produced	NULL
by	NULL
mouse	NULL
monoclonal	NULL
antibodies	NULL
directed	NULL
against	NULL
PML	NULL
(	NULL
panel	NULL
B	NULL
)	NULL
.	NULL

Pretreatment	NULL
of	NULL
rat	NULL
anti-Sp1l40	NULL
antibodies	NULL
with	NULL
recombinant	NULL
protein	NULL
completely	NULL
blocked	NULL
the	NULL
NB	NULL
staining	NULL
pattern	NULL
(	NULL
panel	NULL
C	NULL
)	NULL
.	NULL

Two-color	NULL
immuno-histochemistry	NULL
demonstrated	NULL
that	NULL
rat	NULL
anti-Sp1l40	NULL
antibodies	NULL
and	NULL
mouse	NULL
anti-PML	NULL
antibodies	NULL
localized	NULL
to	NULL
the	NULL
same	NULL
structures	NULL
in	NULL
individual	NULL
cells	NULL
(	NULL
panel	NULL
D	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
cellular	NULL
distribution	NULL
of	NULL
Sp140	NULL
in	NULL
APL	NULL
cell	NULL
line	NULL
NB4	NULL
,	NULL
rat	NULL
antiserum	NULL
was	NULL
used	NULL
to	NULL
stain	NULL
NB4	NULL
cells	NULL
before	NULL
and	NULL
after	NULL
treatment	NULL
with	NULL
RA	NULL
.	NULL

Rat	NULL
antiserum	NULL
directed	NULL
against	NULL
Sp140	NULL
stained	NULL
NBs	NULL
in	NULL
NB4	NULL
cells	NULL
that	NULL
were	NULL
treated	NULL
for	NULL
5	NULL
days	NULL
with	NULL
RA	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
panel	NULL
E	NULL
)	NULL
.	NULL

Mouse	NULL
monoclonal	NULL
antibody	NULL
directed	NULL
against	NULL
PML	NULL
produced	NULL
the	NULL
same	NULL
pattern	NULL
of	NULL
staining	NULL
in	NULL
RA-treated	NULL
NB4	NULL
cells	NULL
(	NULL
panel	NULL
F	NULL
)	NULL
.	NULL

Rat	NULL
anti-Spl40	NULL
antiserum	NULL
did	NULL
not	NULL
stain	NULL
the	NULL
nuclei	NULL
of	NULL
untreated	NULL
NB4	NULL
cells	NULL
(	NULL
panel	NULL
!	NULL

G	NULL
)	NULL
.	NULL

DISCUSSION	NULL
Patients	NULL
with	NULL
the	NULL
autoimmune	NULL
disease	NULL
primary	NULL
biliary	NULL
cirrhosis	NULL
produce	NULL
antibodies	NULL
directed	NULL
against	NULL
components	NULL
of	NULL
a	NULL
cellular	NULL
organelle	NULL
known	NULL
as	NULL
the	NULL
nuclear	NULL
body	NULL
.	NULL

Two	NULL
proteins	NULL
in	NULL
the	NULL
NB	NULL
,	NULL
Sp100	NULL
and	NULL
PML	NULL
,	NULL
have	NULL
previously	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
targets	NULL
of	NULL
autoantibodies	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
serum	NULL
from	NULL
a	NULL
patient	NULL
with	NULL
PBC	NULL
was	NULL
used	NULL
to	NULL
identify	NULL
a	NULL
novel	NULL
NB	NULL
antigen	NULL
which	NULL
was	NULL
designated	NULL
Sp140	NULL
.	NULL

The	NULL
amino-terminal	NULL
portion	NULL
of	NULL
Sp140	NULL
was	NULL
49	NULL
%	NULL
identical	NULL
to	NULL
the	NULL
amino-terminal	NULL
region	NULL
of	NULL
Sp100	NULL
.	NULL

These	NULL
portions	NULL
of	NULL
Sp100	NULL
and	NULL
Sp140	NULL
contain	NULL
potential	NULL
coiled-coil	NULL
motifs	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Koken	NULL
et	NULL
al	NULL
.	NULL

(	NULL
14	NULL
)	NULL
hypothesized	NULL
that	NULL
the	NULL
amino-terminal	NULL
domain	NULL
of	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Sp	NULL
140	NULL
Component	NULL
of	NULL
the	NULL
Nuclear	NULL
Body	NULL
s	NULL
.	NULL

A	NULL
B	NULL
4	NULL
29208	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

Immunohistochemical	NULL
localization	NULL
of	NULL
Sp140	NULL
and	NULL
PML	NULL
in	NULL
HL60	NULL
cells	NULL
treated	NULL
with	NULL
Me	NULL
,	NULL
S8O	NULL
and	NULL
NB4	NULL
cells	NULL
treated	NULL
with	NULL
retinoic	NULL
acid	NULL
.	NULL

Affinity-purified	NULL
rat	NULL
anti-Sp140	NULL
antibodies	NULL
reacted	NULL
with	NULL
dotlike	NULL
regions	NULL
in	NULL
Me	NULL
,	NULL
SO-treated	NULL
HL6O0	NULL
cells	NULL
(	NULL
pare	NULL
?	NULL

A	NULL
)	NULL
.	NULL

The	NULL
same	NULL
staining	NULL
pattern	NULL
was	NULL
seen	NULL
using	NULL
mouse	NULL
monoclonal	NULL
antibodies	NULL
directed	NULL
against	NULL
PML	NULL
(	NULL
panel	NULL
!	NULL

B	NULL
)	NULL
.	NULL

Pretreatment	NULL
of	NULL
rat	NULL
anti-Sp140	NULL
antibodies	NULL
with	NULL
recombinant	NULL
protein	NULL
blocked	NULL
the	NULL
NB	NULL
staining	NULL
pattern	NULL
(	NULL
panel	NULL
C	NULL
)	NULL
.	NULL

Two	NULL
color	NULL
immunohistochemical	NULL
staining	NULL
revealed	NULL
co-localization	NULL
of	NULL
Sp140	NULL
and	NULL
PML	NULL
in	NULL
the	NULL
NBs	NULL
of	NULL
individual	NULL
cells	NULL
(	NULL
panel	NULL
D	NULL
;	NULL
note	NULL
the	NULL
halo	NULL
of	NULL
blue	NULL
surrounding	NULL
brown-staining	NULL
NBs	NULL
,	NULL
as	NULL
indicated	NULL
by	NULL
arrows	NULL
)	NULL
.	NULL

In	NULL
panels	NULL
A	NULL
and	NULL
C	NULL
,	NULL
anti-Sp140	NULL
antibodies	NULL
were	NULL
revealed	NULL
with	NULL
TruBlue	NULL
peroxidase	NULL
substrate	NULL
,	NULL
resulting	NULL
in	NULL
a	NULL
blue	NULL
precipitate	NULL
.	NULL

In	NULL
panels	NULL
B	NULL
and	NULL
D	NULL
,	NULL
mouse	NULL
monoclonal	NULL
anti-PML	NULL
antibodies	NULL
were	NULL
detected	NULL
using	NULL
the	NULL
DAB	NULL
substrate	NULL
,	NULL
resulting	NULL
in	NULL
a	NULL
brown	NULL
precipitate	NULL
.	NULL

In	NULL
co-localization	NULL
studies	NULL
,	NULL
Sp140	NULL
immunoreactivity	NULL
was	NULL
detected	NULL
using	NULL
alkaline	NULL
phosphatase-conjugated	NULL
reagents	NULL
and	NULL
PhThalo	NULL
Blue	NULL
.	NULL

The	NULL
cells	NULL
in	NULL
panels	NULL
A	NULL
,	NULL
C	NULL
,	NULL
and	NULL
D	NULL
were	NULL
counterstained	NULL
lightly	NULL
with	NULL
hematoxylin	NULL
to	NULL
provide	NULL
a	NULL
pale	NULL
blue	NULL
contrast	NULL
,	NULL
while	NULL
cells	NULL
in	NULL
panel	NULL
B	NULL
were	NULL
counterstained	NULL
with	NULL
neutral	NULL
red	NULL
dye	NULL
.	NULL

Rat	NULL
anti-Sp140	NULL
antiserum	NULL
reacted	NULL
with	NULL
NBs	NULL
in	NULL
RA-treated	NULL
NBA4	NULL
cells	NULL
(	NULL
panel	NULL
E	NULL
;	NULL
DAB	NULL
brown	NULL
chromagen	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
NB	NULL
staining	NULL
pattern	NULL
was	NULL
most	NULL
evident	NULL
in	NULL
the	NULL
indicated	NULL
nucleus	NULL
(	NULL
arrow	NULL
)	NULL
,	NULL
faint	NULL
staining	NULL
of	NULL
NBs	NULL
was	NULL
present	NULL
in	NULL
all	NULL
cells	NULL
in	NULL
this	NULL
field	NULL
.	NULL

Mouse	NULL
monoclonal	NULL
antibodies	NULL
directed	NULL
against	NULL
PML	NULL
also	NULL
reacted	NULL
with	NULL
NBs	NULL
in	NULL
RA-treated	NULL
NB4	NULL
cells	NULL
(	NULL
panel	NULL
!	NULL

F	NULL
;	NULL
TruBlue	NULL
peroxidase	NULL
chromagen	NULL
)	NULL
.	NULL

Rat	NULL
antiserum	NULL
did	NULL
not	NULL
react	NULL
with	NULL
untreated	NULL
NB4	NULL
cells	NULL
(	NULL
panel	NULL
!	NULL

@	NULL
)	NULL
.	NULL

Sp100	NULL
was	NULL
a	NULL
likely	NULL
region	NULL
for	NULL
interactions	NULL
between	NULL
Sp100	NULL
and	NULL
``	NULL
other	NULL
PBC	NULL
autoantigens	NULL
.	NULL
``	NULL

A	NULL
direct	NULL
interaction	NULL
between	NULL
Sp100	NULL
and	NULL
Sp140	NULL
has	NULL
not	NULL
yet	NULL
been	NULL
demonstrated	NULL
.	NULL

The	NULL
region	NULL
in	NULL
Sp140	NULL
between	NULL
amino	NULL
acids	NULL
579	NULL
and	NULL
619	NULL
contained	NULL
a	NULL
cysteine-rich	NULL
,	NULL
zinc-finger	NULL
motif	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
a	NULL
zinc-finger	NULL
domain	NULL
in	NULL
Sp1l40	NULL
suggests	NULL
that	NULL
the	NULL
protein	NULL
is	NULL
a	NULL
member	NULL
of	NULL
a	NULL
larger	NULL
family	NULL
of	NULL
proteins	NULL
that	NULL
have	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
control	NULL
of	NULL
development	NULL
,	NULL
cellular	NULL
differentiation	NULL
,	NULL
and	NULL
cell	NULL
growth	NULL
.	NULL

The	NULL
zinc-finger	NULL
region	NULL
may	NULL
bind	NULL
DNA	NULL
directly	NULL
or	NULL
may	NULL
interact	NULL
with	NULL
a	NULL
second	NULL
protein	NULL
to	NULL
form	NULL
a	NULL
dimer	NULL
that	NULL
binds	NULL
DNA	NULL
(	NULL
46-48	NULL
)	NULL
.	NULL

The	NULL
order	NULL
of	NULL
the	NULL
cysteine/histidine	NULL
residues	NULL
in	NULL
Sp140	NULL
(	NULL
C4HC3	NULL
)	NULL
differed	NULL
slightly	NULL
from	NULL
that	NULL
of	NULL
the	NULL
previously	NULL
described	NULL
RING	NULL
finger	NULL
(	NULL
C3HC4	NULL
)	NULL
and	NULL
LIM	NULL
motif	NULL
(	NULL
C2HC5	NULL
)	NULL
.	NULL

Koken	NULL
et	NULL
al	NULL
.	NULL

observed	NULL
that	NULL
the	NULL
C4HC3	NULL
motif	NULL
is	NULL
present	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
proteins	NULL
including	NULL
Drosophila	NULL
trithorax	NULL
and	NULL
its	NULL
human	NULL
homologue	NULL
ALL-1	NULL
and	NULL
proposed	NULL
the	NULL
name	NULL
TTC	NULL
(	NULL
for	NULL
trithorax	NULL
consensus	NULL
)	NULL
for	NULL
this	NULL
family	NULL
of	NULL
proteins	NULL
(	NULL
49	NULL
)	NULL
.	NULL

The	NULL
portion	NULL
of	NULL
Sp1l40	NULL
between	NULL
amino	NULL
acids	NULL
681	NULL
and	NULL
715	NULL
contained	NULL
a	NULL
bromodomain	NULL
.	NULL

The	NULL
bromodomain	NULL
is	NULL
a	NULL
conserved	NULL
sequence	NULL
that	NULL
is	NULL
found	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
transcriptional	NULL
regulatory	NULL
proteins	NULL
(	NULL
43-45	NULL
)	NULL
.	NULL

The	NULL
predicted	NULL
secondary	NULL
structure	NULL
of	NULL
the	NULL
bromodomain	NULL
includes	NULL
two	NULL
strongly	NULL
amphipathic	NULL
«	NULL
helices	NULL
followed	NULL
by	NULL
reverse	NULL
turns	NULL
.	NULL

Although	NULL
the	NULL
functional	NULL
significance	NULL
of	NULL
the	NULL
bromodomain	NULL
is	NULL
unknown	NULL
,	NULL
the	NULL
hydrophobic	NULL
surfaces	NULL
of	NULL
the	NULL
helices	NULL
may	NULL
serve	NULL
as	NULL
sites	NULL
of	NULL
intramolecular	NULL
protein-protein	NULL
interaction	NULL
.	NULL

These	NULL
interactions	NULL
may	NULL
influence	NULL
the	NULL
assembly	NULL
or	NULL
activity	NULL
of	NULL
multicomponent	NULL
complexes	NULL
involved	NULL
in	NULL
transcriptional	NULL
activation	NULL
(	NULL
50	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
Sp140	NULL
in	NULL
Human	NULL
Tissues	NULL
and	NULL
Cell	NULL
Lines-High	NULL
levels	NULL
of	NULL
mRNA	NULL
encoding	NULL
Sp140	NULL
were	NULL
detected	NULL
in	NULL
human	NULL
spleen	NULL
and	NULL
peripheral	NULL
blood	NULL
leukocytes	NULL
and	NULL
much	NULL
lower	NULL
levels	NULL
were	NULL
detected	NULL
in	NULL
all	NULL
other	NULL
tissues	NULL
examined	NULL
.	NULL

The	NULL
predominant	NULL
expression	NULL
of	NULL
Sp140	NULL
in	NULL
human	NULL
leukocytes	NULL
suggests	NULL
that	NULL
Sp140	NULL
may	NULL
have	NULL
an	NULL
important	NULL
role	NULL
in	NULL
cellular	NULL
functions	NULL
that	NULL
are	NULL
unique	NULL
to	NULL
these	NULL
cells	NULL
.	NULL

Low	NULL
levels	NULL
of	NULL
Sp140	NULL
mRNA	NULL
were	NULL
detected	NULL
in	NULL
the	NULL
myeloid	NULL
precursor	NULL
cell	NULL
lines	NULL
HL60	NULL
and	NULL
NB4	NULL
.	NULL

Expression	NULL
of	NULL
Sp140	NULL
in	NULL
HL6O	NULL
cells	NULL
was	NULL
markedly	NULL
increased	NULL
during	NULL
the	NULL
course	NULL
of	NULL
differentiation	NULL
of	NULL
these	NULL
cells	NULL
toward	NULL
either	NULL
monocytes	NULL
or	NULL
polymorphonuclear	NULL
leukocytes	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
expression	NULL
of	NULL
Sp140	NULL
in	NULL
NB4	NULL
cells	NULL
was	NULL
markedly	NULL
increased	NULL
following	NULL
treat	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
29204	NULL
ment	NULL
with	NULL
RA	NULL
,	NULL
which	NULL
induces	NULL
a	NULL
polymorphonuclear	NULL
leukocyte	NULL
morphology	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
Sp140	NULL
may	NULL
have	NULL
a	NULL
role	NULL
in	NULL
the	NULL
differentiation	NULL
of	NULL
myeloid	NULL
precursor	NULL
cells	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
Sp1l40	NULL
was	NULL
not	NULL
limited	NULL
to	NULL
leukocytes	NULL
belonging	NULL
to	NULL
the	NULL
monocyte/granulocyte	NULL
lineage	NULL
.	NULL

Sp140	NULL
mRNA	NULL
was	NULL
also	NULL
detected	NULL
in	NULL
the	NULL
T	NULL
cell	NULL
line	NULL
Hut78	NULL
,	NULL
but	NULL
not	NULL
in	NULL
the	NULL
T	NULL
cell	NULL
line	NULL
Jurkat	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
Sp140	NULL
mRNA	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
B	NULL
cell	NULL
line	NULL
Raji	NULL
,	NULL
but	NULL
not	NULL
in	NULL
B	NULL
cell	NULL
lines	NULL
Ramos	NULL
and	NULL
HS-Sultan	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
significance	NULL
of	NULL
Sp140	NULL
expression	NULL
in	NULL
some	NULL
,	NULL
but	NULL
not	NULL
all	NULL
,	NULL
lymphocyte	NULL
cell	NULL
lines	NULL
is	NULL
not	NULL
known	NULL
.	NULL

Sp140	NULL
Is	NULL
a	NULL
Component	NULL
of	NULL
the	NULL
NB-To	NULL
investigate	NULL
the	NULL
cellular	NULL
distribution	NULL
of	NULL
Sp140	NULL
,	NULL
rat	NULL
antiserum	NULL
directed	NULL
against	NULL
a	NULL
recombinant	NULL
fragment	NULL
of	NULL
Sp140	NULL
was	NULL
produced	NULL
.	NULL

The	NULL
antiserum	NULL
reacted	NULL
in	NULL
immunoblot	NULL
with	NULL
Sp140	NULL
produced	NULL
by	NULL
in	NULL
vitro	NULL
transcription	NULL
and	NULL
translation	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
antiserum	NULL
reacted	NULL
in	NULL
immunoblot	NULL
with	NULL
Sp140	NULL
in	NULL
Me	NULL
,	NULL
SO-treated	NULL
HL6O0	NULL
cells	NULL
.	NULL

By	NULL
immunohistochemical	NULL
staining	NULL
techniques	NULL
,	NULL
Sp140	NULL
co-localized	NULL
with	NULL
PML	NULL
in	NULL
MegSQO-treated	NULL
HL60	NULL
cells	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
Sp140	NULL
is	NULL
a	NULL
component	NULL
of	NULL
the	NULL
NB	NULL
.	NULL

Sp140	NULL
and	NULL
Acute	NULL
Promyelocytic	NULL
Leukemia-In	NULL
APL	NULL
,	NULL
a	NULL
translocation	NULL
between	NULL
chromosomes	NULL
15	NULL
and	NULL
17	NULL
results	NULL
in	NULL
fusion	NULL
of	NULL
the	NULL
NB	NULL
protein	NULL
PML	NULL
to	NULL
RAR-	NULL
«	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
fusion	NULL
protein	NULL
disrupts	NULL
the	NULL
NB	NULL
and	NULL
inhibits	NULL
normal	NULL
myeloid	NULL
maturation	NULL
.	NULL

Treatment	NULL
of	NULL
APL	NULL
cells	NULL
with	NULL
RA	NULL
results	NULL
in	NULL
reformation	NULL
of	NULL
the	NULL
NB	NULL
and	NULL
induces	NULL
leukemic	NULL
cell	NULL
maturation	NULL
(	NULL
8	NULL
,	NULL
9-14	NULL
)	NULL
.	NULL

The	NULL
mechanism	NULL
of	NULL
action	NULL
of	NULL
RA	NULL
in	NULL
these	NULL
cells	NULL
is	NULL
unknown	NULL
.	NULL

The	NULL
myeloid	NULL
precursor	NULL
cell	NULL
line	NULL
NB4	NULL
contains	NULL
the	NULL
t	NULL
(	NULL
15	NULL
;	NULL
17	NULL
)	NULL
translocation	NULL
associated	NULL
with	NULL
APL	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Using	NULL
immunohistochemistry	NULL
,	NULL
Sp140	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
untreated	NULL
NB4	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

7G	NULL
)	NULL
.	NULL

This	NULL
was	NULL
not	NULL
surprising	NULL
in	NULL
view	NULL
of	NULL
the	NULL
low	NULL
level	NULL
of	NULL
Sp140	NULL
mRNA	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

However	NULL
,	NULL
following	NULL
treatment	NULL
of	NULL
NB4	NULL
cells	NULL
with	NULL
RA	NULL
,	NULL
Sp140	NULL
was	NULL
detected	NULL
within	NULL
the	NULL
NBs	NULL
of	NULL
these	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
panel	NULL
E	NULL
)	NULL
.	NULL

The	NULL
observations	NULL
that	NULL
expression	NULL
of	NULL
Sp140	NULL
in	NULL
NB4	NULL
cells	NULL
is	NULL
induced	NULL
by	NULL
RA	NULL
treatment	NULL
and	NULL
that	NULL
Sp140	NULL
associates	NULL
with	NULL
the	NULL
NB	NULL
suggest	NULL
that	NULL
Sp140	NULL
may	NULL
have	NULL
a	NULL
role	NULL
in	NULL
the	NULL
action	NULL
of	NULL
RA	NULL
on	NULL
APL	NULL
cells	NULL
.	NULL

The	NULL
observed	NULL
resistance	NULL
of	NULL
APL	NULL
cells	NULL
to	NULL
RA	NULL
that	NULL
develops	NULL
over	NULL
time	NULL
(	NULL
51	NULL
,	NULL
52	NULL
)	NULL
may	NULL
,	NULL
in	NULL
part	NULL
,	NULL
be	NULL
a	NULL
result	NULL
of	NULL
a	NULL
second	NULL
event	NULL
in	NULL
these	NULL
cells	NULL
that	NULL
alters	NULL
the	NULL
structure	NULL
or	NULL
function	NULL
of	NULL
a	NULL
protein	NULL
(	NULL
possibly	NULL
Sp140	NULL
)	NULL
that	NULL
interacts	NULL
with	NULL
PML	NULL
in	NULL
the	NULL
NB	NULL
.	NULL

Sp140	NULL
and	NULL
Viral	NULL
Infection-IFN	NULL
treatment	NULL
increases	NULL
the	NULL
expression	NULL
of	NULL
each	NULL
of	NULL
the	NULL
previously	NULL
identified	NULL
components	NULL
of	NULL
the	NULL
NB	NULL
(	NULL
Sp100	NULL
,	NULL
PML	NULL
,	NULL
and	NULL
NDP52	NULL
)	NULL
.	NULL

Guldner	NULL
et	NULL
al	NULL
.	NULL

(	NULL
19	NULL
)	NULL
suggested	NULL
that	NULL
Sp100	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
establishing	NULL
an	NULL
``	NULL
anti-viral	NULL
state	NULL
.	NULL
``	NULL

Recently	NULL
,	NULL
Doucas	NULL
et	NULL
al	NULL
.	NULL

(	NULL
20	NULL
)	NULL
demonstrated	NULL
that	NULL
overex-pression	NULL
of	NULL
PML	NULL
in	NULL
HEp2	NULL
cells	NULL
dramatically	NULL
decreased	NULL
the	NULL
ability	NULL
of	NULL
these	NULL
cells	NULL
to	NULL
support	NULL
adenoviral	NULL
replication	NULL
.	NULL

The	NULL
authors	NULL
hypothesized	NULL
that	NULL
increased	NULL
expression	NULL
of	NULL
PML	NULL
may	NULL
delay	NULL
or	NULL
block	NULL
Sp100	NULL
and	NULL
NDP52	NULL
recruitment	NULL
to	NULL
viral	NULL
replication	NULL
domains	NULL
resulting	NULL
in	NULL
inhibition	NULL
of	NULL
viral	NULL
DNA	NULL
replication	NULL
(	NULL
20	NULL
)	NULL
.	NULL

The	NULL
identification	NULL
of	NULL
a	NULL
novel	NULL
NB	NULL
component	NULL
that	NULL
is	NULL
expressed	NULL
in	NULL
cells	NULL
involved	NULL
in	NULL
host	NULL
defense	NULL
raises	NULL
the	NULL
possibility	NULL
that	NULL
Sp140	NULL
may	NULL
also	NULL
have	NULL
a	NULL
role	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
,	NULL
or	NULL
the	NULL
host	NULL
response	NULL
to	NULL
,	NULL
viral	NULL
infection	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
a	NULL
novel	NULL
component	NULL
of	NULL
the	NULL
NB	NULL
has	NULL
been	NULL
identified	NULL
and	NULL
characterized	NULL
.	NULL

The	NULL
predicted	NULL
amino	NULL
acid	NULL
sequence	NULL
of	NULL
Sp140	NULL
suggests	NULL
that	NULL
this	NULL
protein	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
gene	NULL
transcription	NULL
.	NULL

The	NULL
predominant	NULL
expression	NULL
of	NULL
Sp1l40	NULL
in	NULL
leukocytes	NULL
raises	NULL
the	NULL
possibility	NULL
that	NULL
this	NULL
protein	NULL
has	NULL
an	NULL
important	NULL
role	NULL
in	NULL
cellular	NULL
functions	NULL
that	NULL
are	NULL
unique	NULL
to	NULL
these	NULL
cells	NULL
.	NULL

Future	NULL
studies	NULL
of	NULL
Sp140	NULL
may	NULL
provide	NULL
insight	NULL
into	NULL
the	NULL
function	NULL
of	NULL
the	NULL
NB	NULL
and	NULL
the	NULL
role	NULL
of	NULL
this	NULL
organelle	NULL
in	NULL
myeloproliferative	NULL
disease	NULL
,	NULL
viral	NULL
infection	NULL
and	NULL
autoimmune	NULL
disorders	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
D.	NULL
Rabkin	NULL
,	NULL
G.	NULL
Filippov	NULL
and	NULL
D.	NULL
Orth	NULL
for	NULL
technical	NULL
assistance	NULL
and	NULL
K.	NULL
J.	NULL
Bloch	NULL
and	NULL
L.	NULL
Diller	NULL
for	NULL
advice	NULL
and	NULL
critical	NULL
review	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

to	NULL
bo	NULL
|A	NULL
gs	NULL
t	NULL
go	NULL
si	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

28	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41.	NULL
.	NULL

Robbins	NULL
,	NULL
J.	NULL
,	NULL
Dilworth	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Laskey	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
and	NULL
Dingwall	NULL
,	NULL
C.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
64	NULL
,	NULL
43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

Sp	NULL
140	NULL
Component	NULL
of	NULL
the	NULL
Nuclear	NULL
Body	NULL
REFERENCES	NULL
.	NULL

Ascoli	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
and	NULL
Maul	NULL
,	NULL
G.	NULL
G.	NULL
(	NULL
1991	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

112	NULL
,	NULL
785-795	NULL
.	NULL

Brasch	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Ochs	NULL
,	NULL
R.	NULL
L.	NULL
(	NULL
1992	NULL
)	NULL
Exp	NULL
.	NULL

Cell	NULL
Res	NULL
.	NULL

202	NULL
,	NULL
211-223	NULL
.	NULL

Dyck	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Maul	NULL
,	NULL
G.	NULL
G.	NULL
,	NULL
Miller	NULL
,	NULL
W.	NULL
H.	NULL
,	NULL
Jr.	NULL
,	NULL
Chen	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Kakizuka	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Evans	NULL
,	NULL
R.	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
76	NULL
,	NULL
333-343	NULL
.	NULL

Evans	NULL
,	NULL
J.	NULL
,	NULL
Reuben	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Craft	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Arthritis	NULL
Rheum	NULL
.	NULL

84	NULL
,	NULL
731-736	NULL
.	NULL

Szostecki	NULL
,	NULL
C.	NULL
,	NULL
Will	NULL
,	NULL
H.	NULL
,	NULL
Netter	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
and	NULL
Guldner	NULL
,	NULL
H.	NULL
H.	NULL
(	NULL
1992	NULL
)	NULL
Scand	NULL
.	NULL

J.	NULL
Im-	NULL
munol	NULL
.	NULL

86	NULL
,	NULL
555-564	NULL
.	NULL

Szostecki	NULL
,	NULL
C.	NULL
,	NULL
Guldner	NULL
,	NULL
H.	NULL
H.	NULL
,	NULL
Netter	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
and	NULL
Will	NULL
,	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

145	NULL
,	NULL
4838-4347	NULL
.	NULL

Xie	NULL
,	NULL
K.	NULL
,	NULL
Lambie	NULL
,	NULL
E.	NULL
J.	NULL
,	NULL
and	NULL
Snyder	NULL
,	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
6170-6179	NULL
.	NULL

Korioth	NULL
,	NULL
F.	NULL
,	NULL
Gieffers	NULL
,	NULL
C.	NULL
,	NULL
Maul	NULL
,	NULL
G.	NULL
G.	NULL
,	NULL
and	NULL
Frey	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

180	NULL
,	NULL
1-13	NULL
.	NULL

de	NULL
The	NULL
,	NULL
H.	NULL
,	NULL
Chomienne	NULL
,	NULL
C.	NULL
,	NULL
Lanotte	NULL
,	NULL
M.	NULL
,	NULL
Degos	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Dejean	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Nature	NULL
847	NULL
,	NULL
558-561	NULL
Borrow	NULL
,	NULL
J.	NULL
,	NULL
Goddard	NULL
,	NULL
A.	NULL
,	NULL
Sheer	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Solomon	NULL
,	NULL
E.	NULL
(	NULL
1990	NULL
)	NULL
Science	NULL
249	NULL
,	NULL
1577-1580	NULL
Longo	NULL
,	NULL
L.	NULL
,	NULL
Pandolfi	NULL
,	NULL
P.	NULL
P.	NULL
,	NULL
Biondi	NULL
,	NULL
A.	NULL
,	NULL
Rombaldi	NULL
,	NULL
A.	NULL
,	NULL
Mencarelli	NULL
,	NULL
A.	NULL
,	NULL
Lo	NULL
Coco	NULL
,	NULL
F.	NULL
,	NULL
Direrio	NULL
,	NULL
D.	NULL
,	NULL
Pegoraro	NULL
,	NULL
L.	NULL
,	NULL
Avanzi	NULL
,	NULL
G.	NULL
,	NULL
Tabilio	NULL
,	NULL
A.	NULL
,	NULL
Zangrilli	NULL
,	NULL
D.	NULL
,	NULL
Alcalay	NULL
,	NULL
M.	NULL
,	NULL
Donti	NULL
,	NULL
E.	NULL
,	NULL
Grignani	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Pelicci	NULL
,	NULL
P.	NULL
G.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

172	NULL
,	NULL
1571-1575	NULL
Kakizuka	NULL
,	NULL
A.	NULL
,	NULL
Miller	NULL
,	NULL
W.	NULL
H.	NULL
,	NULL
Jr.	NULL
,	NULL
Umesono	NULL
,	NULL
K.	NULL
,	NULL
Warrell	NULL
,	NULL
R.	NULL
P.	NULL
,	NULL
Jr.	NULL
,	NULL
Frankel	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
Murty	NULL
,	NULL
V.	NULL
V.	NULL
V.	NULL
S.	NULL
,	NULL
Dmitrovsky	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Evans	NULL
,	NULL
R.	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
66	NULL
,	NULL
663-674	NULL
Weis	NULL
,	NULL
K.	NULL
,	NULL
Rambaud	NULL
,	NULL
S.	NULL
,	NULL
Lavau	NULL
,	NULL
C.	NULL
,	NULL
Jansen	NULL
,	NULL
J.	NULL
,	NULL
Carvalho	NULL
,	NULL
T.	NULL
,	NULL
Carmo-Fonseca	NULL
,	NULL
M.	NULL
,	NULL
Lamond	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Dejean	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Cell	NULL
76	NULL
,	NULL
345-356	NULL
Koken	NULL
,	NULL
M.	NULL
H.	NULL
M.	NULL
,	NULL
Puvion-Dutilleul	NULL
,	NULL
F.	NULL
,	NULL
Guillemin	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Viron	NULL
,	NULL
A.	NULL
,	NULL
Linares-Cruz	NULL
,	NULL
G.	NULL
,	NULL
Stuurman	NULL
,	NULL
N.	NULL
,	NULL
de	NULL
Jong	NULL
,	NULL
L.	NULL
,	NULL
Szostecki	NULL
,	NULL
C.	NULL
,	NULL
Calvo	NULL
,	NULL
F.	NULL
,	NULL
Chomienne	NULL
,	NULL
C.	NULL
,	NULL
Degos	NULL
,	NULL
L.	NULL
,	NULL
Puvion	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
de	NULL
The	NULL
,	NULL
H.	NULL
(	NULL
1994	NULL
)	NULL
EMBO	NULL
18	NULL
,	NULL
1073-1083	NULL
Warrell	NULL
,	NULL
R.	NULL
P.	NULL
,	NULL
de	NULL
The	NULL
,	NULL
H.	NULL
,	NULL
Wang	NULL
,	NULL
Z.-Y	NULL
.	NULL

,	NULL
and	NULL
Degos	NULL
,	NULL
L.	NULL
(	NULL
1998	NULL
)	NULL
N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

829	NULL
,	NULL
177-189	NULL
Daniel	NULL
,	NULL
M.	NULL
T.	NULL
,	NULL
Koken	NULL
,	NULL
M.	NULL
,	NULL
Romagne	NULL
,	NULL
O.	NULL
,	NULL
Barbey	NULL
,	NULL
S.	NULL
,	NULL
Bazarbachi	NULL
,	NULL
A.	NULL
,	NULL
Stadler	NULL
,	NULL
M.	NULL
,	NULL
Guillemin	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Degos	NULL
,	NULL
L.	NULL
,	NULL
Chomienne	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
de	NULL
The	NULL
,	NULL
H.	NULL
(	NULL
1993	NULL
)	NULL
Blood	NULL
82	NULL
,	NULL
1858-1867	NULL
Koken	NULL
,	NULL
M.	NULL
H.	NULL
M.	NULL
,	NULL
Linares-Cruz	NULL
,	NULL
G.	NULL
,	NULL
Quignon	NULL
,	NULL
F.	NULL
,	NULL
Viron	NULL
,	NULL
A.	NULL
,	NULL
Chelbi-Alix	NULL
,	NULL
M.	NULL
K.	NULL
,	NULL
Sobczak-Thepot	NULL
,	NULL
J.	NULL
,	NULL
Juhlin	NULL
,	NULL
L.	NULL
,	NULL
Degos	NULL
,	NULL
L.	NULL
,	NULL
Calvo	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
de	NULL
The	NULL
,	NULL
H.	NULL
(	NULL
1995	NULL
)	NULL
Oncogene	NULL
10	NULL
,	NULL
1815-1324	NULL
Sternsdorf	NULL
,	NULL
T.	NULL
,	NULL
Guldner	NULL
,	NULL
H.	NULL
H.	NULL
,	NULL
Szostecki	NULL
,	NULL
C.	NULL
,	NULL
Grotzinger	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Will	NULL
,	NULL
H.	NULL
(	NULL
1995	NULL
)	NULL
Scand	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

42	NULL
,	NULL
257-268	NULL
Guldner	NULL
,	NULL
H.	NULL
H.	NULL
,	NULL
Szostecki	NULL
,	NULL
C.	NULL
,	NULL
Grotzinger	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Will	NULL
,	NULL
H.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

149	NULL
,	NULL
4067-4073	NULL
Doucas	NULL
,	NULL
V.	NULL
,	NULL
Ishov	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Romo	NULL
,	NULL
A.	NULL
,	NULL
Juguilon	NULL
,	NULL
H.	NULL
,	NULL
Weitzman	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
Evans	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
and	NULL
Maul	NULL
,	NULL
G.	NULL
G.	NULL
(	NULL
1996	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

10	NULL
,	NULL
196-207	NULL
Maul	NULL
,	NULL
G.	NULL
G.	NULL
,	NULL
Guldner	NULL
,	NULL
H.	NULL
H.	NULL
,	NULL
and	NULL
Spivack	NULL
,	NULL
J.	NULL
G.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Gen.	NULL
Virol	NULL
.	NULL

74	NULL
,	NULL
2679-2690	NULL
Maul	NULL
,	NULL
G.	NULL
G.	NULL
,	NULL
and	NULL
Everett	NULL
,	NULL
R.	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Gen.	NULL
Virol	NULL
.	NULL

75	NULL
,	NULL
1223-1233	NULL
Puvion-Dutilleul	NULL
,	NULL
F.	NULL
,	NULL
Chelbi-Alix	NULL
,	NULL
M.	NULL
K.	NULL
,	NULL
Koken	NULL
,	NULL
M.	NULL
,	NULL
Quignon	NULL
,	NULL
F.	NULL
,	NULL
Puvion	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
de	NULL
The	NULL
,	NULL
H.	NULL
(	NULL
1995	NULL
)	NULL
Exp	NULL
.	NULL

Cell	NULL
Res	NULL
.	NULL

218	NULL
,	NULL
9-16	NULL
Carvalho	NULL
,	NULL
T.	NULL
,	NULL
Seeler	NULL
,	NULL
J.-S.	NULL
,	NULL
Ohman	NULL
,	NULL
K.	NULL
,	NULL
Jordan	NULL
,	NULL
P.	NULL
,	NULL
Pettersson	NULL
,	NULL
U.	NULL
,	NULL
Akusjarvi	NULL
,	NULL
G.	NULL
,	NULL
Carmo-Fonseca	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Dejean	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

181	NULL
,	NULL
45-56	NULL
Kaplan	NULL
,	NULL
M.	NULL
M.	NULL
(	NULL
1987	NULL
)	NULL
N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

816	NULL
,	NULL
521-528	NULL
Collins	NULL
,	NULL
S.	NULL
J	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Blood	NULL
70	NULL
,	NULL
1233-1244	NULL
Collins	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Ruscetti	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
Gallagher	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
and	NULL
Gallo	NULL
,	NULL
R.	NULL
C.	NULL
(	NULL
1978	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

,	NULL
U.	NULL
S.	NULL
A	NULL
.	NULL

75	NULL
,	NULL
2458-2462	NULL
Lanotte	NULL
,	NULL
M.	NULL
,	NULL
Matrin-Thouvenin	NULL
,	NULL
V.	NULL
,	NULL
Najman	NULL
,	NULL
S.	NULL
,	NULL
Balerini	NULL
,	NULL
P.	NULL
,	NULL
Valensi	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Berger	NULL
,	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
Blood	NULL
77	NULL
,	NULL
1080-1086	NULL
Stuurman	NULL
,	NULL
N.	NULL
,	NULL
de	NULL
Graaf	NULL
,	NULL
A.	NULL
,	NULL
Floore	NULL
,	NULL
A.	NULL
,	NULL
Josso	NULL
,	NULL
A.	NULL
,	NULL
Humbel	NULL
,	NULL
B.	NULL
,	NULL
de	NULL
Jong	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
van	NULL
Driel	NULL
,	NULL
R.	NULL
(	NULL
1992	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
Sci	NULL
.	NULL

101	NULL
,	NULL
773-784	NULL
Young	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
and	NULL
Davis	NULL
,	NULL
R.	NULL
W.	NULL
(	NULL
1983	NULL
)	NULL
Science	NULL
222	NULL
,	NULL
778-782	NULL
Staunton	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
Marlin	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
Stratowa	NULL
,	NULL
C.	NULL
,	NULL
Dustin	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
and	NULL
Springer	NULL
,	NULL
T.	NULL
A	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Cell	NULL
52	NULL
,	NULL
925-9833	NULL
Frohman	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Dush	NULL
,	NULL
M.	NULL
K.	NULL
,	NULL
and	NULL
Martin	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

85	NULL
,	NULL
8998-9002	NULL
Sanger	NULL
,	NULL
F.	NULL
(	NULL
1981	NULL
)	NULL
Science	NULL
214	NULL
,	NULL
1205-1210	NULL
Smith	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
and	NULL
Johnson	NULL
,	NULL
K.	NULL
S.	NULL
(	NULL
1988	NULL
)	NULL
Gene	NULL
(	NULL
Amst	NULL
.	NULL
)	NULL

67	NULL
,	NULL
31-40	NULL
Olmsted	NULL
,	NULL
J	NULL
.	NULL

B	NULL
.	NULL

(	NULL
1981	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

256	NULL
,	NULL
11955-11957	NULL
Laemmli	NULL
,	NULL
U.	NULL
K.	NULL
(	NULL
1970	NULL
)	NULL
Nature	NULL
227	NULL
,	NULL
680-685	NULL
Towbin	NULL
,	NULL
H.	NULL
,	NULL
Stachelin	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Gordan	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1979	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

76	NULL
,	NULL
4350-4354	NULL
Sambrook	NULL
,	NULL
J.	NULL
,	NULL
Fritsh	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
Molecular	NULL
Cloning	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
,	NULL
pp	NULL
.	NULL

7.2-7.84	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
Lee	NULL
,	NULL
R.	NULL
T.	NULL
,	NULL
Bloch	NULL
,	NULL
K.	NULL
D.	NULL
,	NULL
Pfeffer	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Pfeffer	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Neer	NULL
,	NULL
E.	NULL
J.	NULL
,	NULL
and	NULL
Seidman	NULL
,	NULL
C.	NULL
E.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

81	NULL
,	NULL
481-434	NULL
Silver	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Cell	NULL
64	NULL
,	NULL
489-497	NULL
Dingwall	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Laskey	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

16	NULL
,	NULL
478-481	NULL
615-623	NULL
Tamkun	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Deuring	NULL
,	NULL
R.	NULL
,	NULL
Scott	NULL
,	NULL
M.	NULL
P.	NULL
,	NULL
Kissinger	NULL
,	NULL
M.	NULL
,	NULL
Pattatucci	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Kaufman	NULL
,	NULL
T.	NULL
C.	NULL
,	NULL
and	NULL
Kennison	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Cell	NULL
68	NULL
,	NULL
561-572	NULL
Haynes	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
Dollard	NULL
,	NULL
C.	NULL
,	NULL
Winston	NULL
,	NULL
F.	NULL
,	NULL
Beck	NULL
,	NULL
S.	NULL
,	NULL
Trowsdale	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Dawid	NULL
,	NULL
I	NULL
.	NULL

B	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20	NULL
,	NULL
2603	NULL
Lygerou	NULL
,	NULL
Z.	NULL
,	NULL
Conesa	NULL
,	NULL
C.	NULL
,	NULL
Lesage	NULL
,	NULL
P.	NULL
,	NULL
Swanson	NULL
,	NULL
R.	NULL
N.	NULL
,	NULL
Ruet	NULL
,	NULL
A.	NULL
,	NULL
Carlson	NULL
,	NULL
M.	NULL
,	NULL
Sentenac	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Seraphin	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

22	NULL
,	NULL
5382-5340	NULL
Schleif	NULL
,	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
Science	NULL
241	NULL
,	NULL
1182-1187	NULL
Struhl	NULL
,	NULL
K.	NULL
(	NULL
1989	NULL
)	NULL
Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

14	NULL
,	NULL
187-140	NULL
Freemont	NULL
,	NULL
P.	NULL
S.	NULL
(	NULL
1993	NULL
)	NULL
Ann	NULL
.	NULL

N.	NULL
Y.	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

684	NULL
,	NULL
174-192	NULL
Koken	NULL
M	NULL
,	NULL
H.	NULL
,	NULL
Saib	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
de	NULL
The	NULL
,	NULL
H.	NULL
(	NULL
1995	NULL
)	NULL
C.	NULL
R.	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

Ser	NULL
.	NULL

III	NULL
Sci	NULL
.	NULL

Vie	NULL
318	NULL
,	NULL
733-739	NULL
Carlson	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Laurent	NULL
,	NULL
B.	NULL
C.	NULL
(	NULL
1994	NULL
)	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

6	NULL
,	NULL
396-402	NULL
Ruchaud	NULL
,	NULL
S.	NULL
,	NULL
Duprez	NULL
,	NULL
E.	NULL
,	NULL
Gendron	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Houge	NULL
,	NULL
G.	NULL
,	NULL
Genieser	NULL
,	NULL
H.	NULL
G.	NULL
,	NULL
Jastroff	NULL
,	NULL
B.	NULL
,	NULL
Doskeland	NULL
,	NULL
S.	NULL
O.	NULL
,	NULL
and	NULL
Lanotte	NULL
,	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

91	NULL
,	NULL
8428-8432	NULL
Warrell	NULL
,	NULL
R.	NULL
P.	NULL
(	NULL
1993	NULL
)	NULL
Blood	NULL
82	NULL
,	NULL
1949-1953	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Identification	NULL
and	NULL
Characterization	NULL
of	NULL
a	NULL
Leukocyte-specific	NULL
Component	NULL
of	NULL
the	NULL
Nuclear	NULL
Body	NULL
Donald	NULL
B.	NULL
Bloch	NULL
,	NULL
Suzanne	NULL
M.	NULL
de	NULL
la	NULL
Monte	NULL
,	NULL
Pavel	NULL
Guigaouri	NULL
,	NULL
Andrew	NULL
Filippov	NULL
and	NULL
Kenneth	NULL
D.	NULL
Bloch	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1996	NULL
,	NULL
271:29198-29204.	NULL
doi	NULL
:	NULL
10.1074/jb0.271.46.29198	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/271/46/29198	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
51	NULL
references	NULL
,	NULL
22	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
.	NULL

full.html	NULL
#	NULL
ref-list-1	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
4q	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL

